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The recent rapid increases in population movements across borders highlight the importance of reliable 
data on refugee and migrant health for public health planning. This scoping report examined evidence on 
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SUMMARY
The issue
Rapid increases in population movements across borders in recent years have 
highlighted the importance of reliable data on refugee and migrant health for 
public health planning. However, such data are not always systematically collected 
by country health information systems in the WHO European Region. A health 
information system includes all activities and resources aimed at ensuring the 
production, analysis, dissemination and reporting of health information for 
public health monitoring. It also includes some less tangible elements necessary 
for operating a health information system, such as governance mechanisms and 
legal frameworks, interinstitutional relationships and values. The Strategy and 
action plan for refugee and migrant health in the WHO European Region, the Global 
action plan promoting the health of refugees and migrants and the Global compact 
for safe, orderly and regular migration all emphasize the need to strengthen health 
information systems and incorporate refugee and migrant health-related variables 
into national datasets. To monitor progress towards this goal, and to determine the 
current status, synthesized information on the various data collection practices is 
needed. Furthermore, an overview of policy considerations towards refugee- and 
migrant-sensitive health information systems is required to inform public health 
decision-making at the national and European levels, taking into account the 
ethical considerations of collecting, using and disseminating data on refugee and 
migrant health.
The synthesis question
The objective of this review is to address the question: “What is the evidence on 
availability and integration of refugee and migrant health data in health information 
systems in the WHO European Region?”
Types of evidence
Evidence was obtained by conducting a scoping review of peer-reviewed and 
grey literature published in English, German and Russian between 2000 and 
2018. The review considered two types of evidence: (i) theoretical and empirical 
studies analysing the health information system in one or more countries of the 
WHO European Region with respect to data on refugee and migrant health and 
(ii) empirical studies and reports using systematically collected data from such 
systems to answer a specific question related to refugee and migrant health. 
ix
A total of 41 studies analysing elements of country health information systems 
with respect to data on refugee and migrant health were included in the review. 
A further 696 studies using data from health information systems were reviewed 
based on their abstracts to systematically derive information on data sources, 
data collection practices and available data on health outcomes among refugees 
and migrants in countries of the WHO European Region.
Results
Research literature on the availability and integration of refugee and migrant 
health data is fragmented. Most of the studies identified assessed highly specific 
data sources, disease entities or areas. Studies focusing on more than one data 
collection source in European countries, or in national health information systems 
as a whole, were rare. Current knowledge about the different elements of the 
health information system is disjointed. Although some evidence was found on the 
availability of refugee and migrant health data, evidence on data quality (a crucial 
aspect of availability), integration of systems and policy initiatives to strengthen data 
collection for migrants was much less frequent. Furthermore, the existing evidence 
was geographically biased towards Scandinavian and central European countries 
for routinely collected data and towards western and southern European countries 
for infectious disease surveillance. Very little information is currently available on 
systematic data collection mechanisms for refugees and migrants in eastern Europe.
Data on refugee and migrant health were available in 25 of the 53 Member States of 
the WHO European Region, but the extent of availability, type of data and main data 
sources differed greatly. Data sources that recorded data on refugee and migrant 
health were diverse and their integration into national health information systems 
was limited, except for population registers, notification systems and medical 
records in some countries. Underused strategies to improve data availability are 
to increase the inclusion of refugees and migrants in health monitoring surveys by 
means of innovative, refugee- and migrant-sensitive mechanisms for recruitment, 
sampling and data collection, and to increase the use of data linkage in countries 
with decentralized, fragmented health systems.
Policy considerations
Based on the findings of the review, the main policy considerations for the WHO 
European Region are to:
• facilitate the harmonization of indicators and definitions of refugee and 
migrant status in health information systems in the WHO European Region 
x
to mitigate challenges in cross-border comparability due to heterogeneous 
definitions;
• designate a supranational body to be responsible for governance, leadership 
and oversight of data collection on refugee and migrant health to foster 
better coordination, cross-country exchange and learning, as well as 
harmonization of data collection strategies (including data quality, integration 
and protection); and
•  regularly monitor the performance of European health information systems 
regarding the availability and integration of refugee and migrant health data 
using appropriate assessment tools.
The main policy considerations for improving health information systems at 
country level are to:
• strengthen existing health information systems for the general population 
because this is also likely to improve the availability of data on refugee and 
migrant health;
•  integrate key data elements related to refugees and migrants (e.g. country of 
birth, nationality, length of stay, reason for migration) into existing data 
collection systems to facilitate stratified data analysis, identify at-risk subgroups 
and ensure cross-border comparability;
•  establish and/or strengthen a tailored, proactive approach to data collection 
for refugees and migrants that addresses the difficulties in accessing these 
populations, their limited access to health care, their language barriers and 
the small sample sizes;
•  utilize and scale up national health monitoring surveys to effectively integrate 
refugees and migrants and facilitate better linkage of survey data with civil/
vital registration data; and
•  establish and/or strengthen data linkages across records (e.g. population 
registers, facility-based records and household surveys) in order to:
 – maximize the available health information, particularly in countries 
where refugee and migrant health data are not routinely collected due to 
decentralized health information systems and lack of civil registrations; and
 –  generate comprehensive information on refugee and migrant health by 
combining information on health service utilization and migration status.
1
1. INTRODUCTION 
1.1  Background
The number of international migrants has increased substantially in recent decades. 
In 2017, the WHO European Region was home to around 90.7 million international 
migrants, corresponding to almost 10% of its total population and 35% of all 
international migrants (1). There has been a dramatic increase in the number of 
refugees, both globally and in the WHO European Region. Furthermore, population 
movements have been characterized by a mixed flow of labour migrants, refugees, 
asylum seekers, irregular migrants and victims of trafficking. It is acknowledged that 
all nations are increasingly becoming countries of origin, transit and destination, 
and that migration has been and will continue to be a reality in every society (2). 
Therefore, health information systems need to adapt accordingly to collect, analyse 
and disseminate timely data on health for an increasingly mobile population.
Monitoring refugee and migrant health through relevant data is an important public 
health strategy. Data on refugee and migrant health, including data on the social 
determinants of health and on the accessibility and utilization of health services, 
are essential for monitoring, safeguarding and promoting the health of refugee, 
migrant and host populations. The need for strong data collection and reporting 
has been identified in a WHO Health Evidence Network synthesis report (3), 
the Strategy and action plan for refugee and migrant health in the WHO European 
Region (4), the Global compact on refugees (5), the Global compact for safe, orderly 
and regular migration (6), the recent draft WHO global action plan to promote the 
health of refugees and migrants (7) and the academic literature (8–12).
Studies reviewing health information systems in Europe have found that many 
countries lack systems to collect data on refugee and migrant health, thus limiting 
the ability to appropriately respond to current needs and plan for the future (8–10,12). 
A recent survey conducted by the WHO Regional Office for Europe found that only 
20 of the 40 responding Member States routinely collected and included data on 
migration-related variables in their existing national datasets (1). However, information 
is not available on the frequency of data collection, the variables included and at 
the level of data collection (health centre, community, national or regional).
Strong health information systems play an important role for evidence-informed 
policy-making because timely, reliable data on health status, risks factors and 
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health determinants, health-care access, quality of care, health-care costs and 
coverage with required interventions and programmes are required to inform 
policies and programme implementation. Such data are necessary not only to 
prevent any potential disease outbreaks but also to protect and promote the 
health of refugees and migrants and the host population. Such systems will help to 
mitigate concerns, which are not necessarily based on evidence, that migrants are 
a threat to public health in countries of the WHO European Region (2). However, 
developing a robust information system or adapting existing systems to collect 
health data for refugees and migrants is challenging, because of both the diversity 
and the mobility of refugee and migrant populations (2). Further challenges include 
the potential misuse of such data for political stigmatization campaigns against 
refugees and migrants, as well as the inappropriate access of migration authorities 
to sensitive health data (2).
The issue of data collection is further complicated by the varying definitions of 
migrant used in the WHO European Region and how this information is obtained, 
which compromise the comparability of data across or even within countries (9,13). 
Guidelines and minimum required datasets have been developed to improve the 
availability of comparable data at the national (14–16) and European Union (EU)/
European Economic Area (EEA) levels (17), but no processes are yet in place to align 
indicators or share best practices in refugee- and migrant-sensitive data collection (18).
In order to adequately respond to the health-monitoring needs of refugee and 
migrant populations, health information systems must not only address these 
challenges but also generate timely, reliable data from a wide range of sources. 
Components of a health information system include data sources, but also 
financial and human resources and less tangible factors such as governance 
mechanisms, policy frameworks, institutional relationships and values. The task 
of health information systems is “the production, analysis, dissemination and 
use of reliable and timely information on health determinants, health systems 
performance and health status, both on regular basis and in emergencies” (19). 
To this end, health information systems gather information from a wide range of 
data sources, including population- and facility-based censuses, household and 
health monitoring surveys, civil registration systems, public health surveillance and 
notification systems, medical records, and health services and health system records 
(e.g. records on human resources, infrastructure or financing) (20). Data are usually 
generated via different data collection modes either directly from populations or 
from the operations of health or other institutions. The data sources underlying 
a health information system can hence be grouped into different data collection 
categories (20). Fig. 1 gives a simplified overview of relevant data collection categories.
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1.1.1  WHO policies, plans and strategies
In recent years, WHO has adopted several resolutions relevant for refugee and 
migrant health (21–26). At a global level, the WHO framework of priorities and 
guiding principles to promote the health of refugees and migrants was presented and 
approved at the Seventieth World Health Assembly (26) and reaffirmed in the recent 
draft global action plan (7). One of the priorities in the framework is to strengthen 
health monitoring and health information systems. Monitoring refugee and migrant 
health was identified as a key component in implementing resolutions WHA61.17 and 
WHA70.15 on health of migrants (21,24) and in WHA71.15 on the implementation of 
the International Health Regulations (25). This resolution highlights the importance 
of collecting relevant data on refugee and migrant health to substantiate evidence-
informed policies and of standardizing and increasing comparability of data on 
refugee and migrant health. At a regional level, the recently adopted Strategy and 
Notification and 
surveillance systems
Health recordsPopulation-based records
Medical 
(hospital) 
records
Claims  
data
Disease-
specific 
registries
Health monitoring 
surveys
Clinical case 
registries
Public health 
service records
Laboratory 
registries
Population 
panels Cohorts
Repeat 
surveys
Population 
registry
Population 
census
Birth registryDeath registry
Health 
information 
system
Fig. 1. A simplified overview of a health information system with different data 
collection categories
Notes: light blue boxes: secondary data, routine statistics; dark blue box: primary data, self-reports
based on questionnaires or standardized interviews.
Source: adapted from World Health Organization, 2008 (20).
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action plan for refugee and migrant health in the WHO European Region emphasizes 
the need to strengthen health information systems and incorporate refugee and 
migrant health-related variables into national datasets (24). Incorporating such data 
enables the analysis of population health data to be disaggregated by refugee and 
migration status, thus substantially contributing to the creation of refugee- and 
migrant-sensitive health information systems.
1.1.2  Objectives of this report
Synthesized information on data collection practices, including the integration 
of refugee and migrant health information into nationwide datasets, is needed 
to monitor progress towards the goal of creating refugee- and migrant-sensitive 
health information systems in the WHO European Region.
This scoping review systematically examines the evidence base to address the 
question “What is the evidence on availability and integration of refugee and 
migrant health in health information systems in the WHO European Region?”
1.2  Methodology
A literature search was carried out of peer-reviewed and grey literature in English 
and Russian between December 2018 and March 2019 to identify evidence on the 
availability and integration of refugee and migrant health data in health information 
systems in the WHO European Region. Studies published from January 2000 to 
December 2018 in English, German or Russian were included in a scoping review.
The search of peer-reviewed literature identified 14 196 articles and the search 
of grey literature identified 226 articles. Two selection strategies were used to 
review and synthesize studies reporting evidence on health information systems 
(strategy 1) and research using routinely collected data (strategy 2). After screening 
and duplicate removal, 76 abstracts were identified as reporting evidence on 
routine data sources; of these, 41 were included for narrative synthesis after 
full-text screening (strategy 1) (9,11,12,26–63). A further 696 abstracts were identified 
as reporting research using routinely collected data and were included for abstract 
extraction and quantitative analysis (strategy 2).
See Annex 1 for full details of the methodology, including the inclusion criteria, 
selection and analysis process of search strategies 1 and 2; Annex 2 for definitions of 
terms used in the scoping review and Annex 3 for the list of 696 studies identified 
via strategy 2.
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2. RESULTS
The review synthesized evidence obtained through two main strategies. Strategy 1 
identified the gaps in the current evidence base on the availability and integration 
of refugee and migrant health data into health information systems. Strategy 2 
identified a large number of studies using routinely collected data in the WHO 
European Region to study a given scientific question related to refugee and migrant 
health. Although this second set did not directly answer the synthesis question, 
the inclusion provided relevant information on the ability of health information 
systems to collect routine data on refugee and migrant health. Therefore, 
the combined use of strategies 1 and 2 allowed comprehensive, high-level mapping 
of the available sources of routine data, as well as a more in-depth consideration 
of the integration of these data in country health information systems. Particularly 
informative examples of the approaches used for, and sources of, routine data 
collection identified by these two strategies were selected as case studies to 
highlight details of their specific features, characteristics or approaches used.
2.1  Evidence on health information systems
Strategy 1 identified a total of 41 peer-reviewed studies on the availability and 
integration of refugees and migrants in data collection. These studies are highly 
diverse, reflecting the availability, quality and attributes of the varied data collection 
mechanisms in the WHO European Region. Only three studies took a broader 
view of health information systems for refugees and migrants, through using 
literature reviews or expert surveys to assess the availability of data on refugee 
and migrant health in several countries and in more than one data collection 
category (9,12,26). All other studies focused on single data collection categories 
or disease outcomes.
2.1.1  Population-based records
A total of 19 studies considered the availability and quality of population-based 
records (civil registration, vital registration, census data) for refugee and migrant 
health. A survey of 27 EU Member States found that 24 had national death registers 
that enabled disaggregation by migrant status, while 11 recorded migrant status in 
register data on health service utilization (9). The remaining 18 studies considered 
registers for refugee and migrant health in one of five European countries: Denmark, 
Germany, the Netherlands, Sweden and the United Kingdom.
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Eight studies described population-based registers routinely used in refugee and 
migrant health research in Denmark and Sweden (26–33). In both countries, 
a personal identifier is provided to each person either at birth or at a specified 
time after entry for refugees and migrants. The data recorded include country of 
birth, citizenship, date of immigration and nationality of both parents. Refugees 
and migrants can thus be identified through their personal identifier and their data 
linked across national registers, including on health and health care, education, 
and labour (27–31). Swedish and Danish population registers are reported to 
provide data of high quality (i.e. with respect to completeness, validity of outcomes 
and national geographical scope) and timeliness (i.e. routine data are readily 
available) (28,30). These studies highlight the significance and quality of linked 
national registers because this approach provides large-scale, representative and 
long-term population samples over time; avoids loss to follow-up; and is easy to 
execute (28,30–32). The limitations and shortcomings of register data compared 
with data collected through health monitoring surveys include the scarcity of 
individual-level data (e.g. reason for migration, self-perceived integration, self-
reported health), lack of data on ethnicity and difficulty of access for international 
researchers (28,33).
A further seven studies were performed in Germany (12,34–39), where routine data 
are mostly available at a regional level and coding of refugees and migrants is limited 
to a classification of German versus non-German nationality, if included at all (34,35). 
One study assessed the overall capacity of the health information system in Germany 
to capture information on asylum seekers across three dimensions: (i) availability 
and level of detail across data sources; (ii) resources and monitoring capacity; and 
(iii) coverage and timeliness of key indicators (12). Capacity was rated on 50 items and 
transformed to a weighted summary score ranging from zero (minimum capacity, 
100% gap) to 97 (maximum capacity, 0% gap). The study found a capacity gap of 
90% on data availability for asylum seekers, in stark contrast to a capacity gap of 
40% in the Netherlands (12). Two studies commented that routine data collection in 
Germany has been set up for managerial and financial purposes by health insurance 
companies; therefore, it does not provide a comprehensive overview of the health 
needs of refugees and migrants because it precludes important epidemiological 
considerations such as length of stay or reason for migration (34,35). To improve 
routine data, the studies suggested that these important factors should be included 
in official statistics and that data reporting should be harmonized across regions. 
To address the gaps in data provision on migrant health in Germany, four studies 
considered the use of innovative identification and linkage approaches. Two used 
name-based algorithms to identify migrants in regional population registers (36) 
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or cancer registers (37), concluding that these approaches are a practicable and 
useful way to identify migrants in official data sources. Two assessed the possibility 
of data linkage (i.e. a strategy to link individual-level data from different relevant 
records) between population registers and decentralized death registers to analyse 
migrant mortality (36,38), showing that these approaches can be reliably used to 
assess mortality and cause of death (36,38) or establish large population-based 
cohorts (38), even without centralized population registers. A further study analysed 
patient complaints to the Office of the Federal Government Commissioner for 
Patient Issues to assess the quality of care for migrant populations: it found that, 
although this complaint register can be a useful source of information on quality 
of care, information on migration status was incomplete and, consequently, not fit 
for migrant-sensitive data analysis (39).
A feasibility study in the United Kingdom assessed the potential use of Migrant 
Workers Scan data (which covers all international migrants applying for a national 
insurance number in the United Kingdom) to improve migration and population 
statistics. The study concluded that this dataset is of high quality and has the potential 
to improve population statistics for migrants, including birth and death registers (40).
One study on migrant deaths along the Spanish–African borders explored the 
reliability of data from surveillance systems and media reports to monitor mortality 
during migrant journeys (41). The study assessed the feasibility of using data 
on departures, fatalities and arrivals to calculate migrant mortality rates and 
showed that caution is required in interpreting these surveillance data because 
assumptions about uncertainty in numerators and denominators1 substantially 
affect the resulting rates.
2.1.2  Notification and surveillance systems for infectious disease
In all, 14 studies examined the availability, quality and comparability of notification 
and surveillance systems for infectious diseases. Infectious disease is a long-standing 
concern of refugee and migrant health research (9) and, therefore, several surveillance 
systems enable a disaggregated analysis of refugee and migrant health. The available 
studies can be divided into those that consider specific health issues or diseases at 
EU/EEA level and those that assess notification systems at a national level.
1. The numerator is the part of a fraction above the line and the denominator is the part of a fraction below 
the line that functions as the divisor of the numerator. In epidemiology, the numerator is usually the 
number of cases of a given health outcome or condition and the denominator is usually the population 
under study or the population at risk of a given health outcome or condition.
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2.1.2.1  EU/EEA level
Five articles on the availability of infectious disease surveillance data for specific 
issues found that data on refugee and migrant health are neither complete 
nor integrated into the health information systems of Member States (42–46). 
For example, a study combining a survey approach and literature review to identify 
policy and surveillance systems for tuberculosis (TB) screening among refugees 
and migrants in EU/EEA Member States found that databases on TB screening 
lacked the sociodemographic data essential for epidemiological analysis (42). 
Another study combining a literature review, survey approach and stakeholder 
meeting to assess the burden of measles among migrants in the EU/EEA found 
that data sources about measles did not systematically record migration status (43). 
A survey study reported that data on immunization coverage in Mediterranean 
countries were not disaggregated by different mobile population groups (44).
Regarding HIV monitoring, a survey study of EU/EEA countries found that although 
13 countries carried out behavioural surveillance (a valuable addition to biological 
surveillance for HIV and other sexually transmitted diseases), only three include 
information on migration status (45). Another survey study assessed the availability 
of national estimates on the continuum of HIV care (including diagnosis, treatment 
and treatment outcome) in 55 European and central Asian countries (46). Of these, 
29 countries reported data for the general population across all four stages of the 
continuum (living with HIV, being diagnosed, receiving treatment and achieving 
viral suppression), but only two countries (Austria and France) did this for migrants. 
Evidence from these two countries highlights the relevance of disaggregated analysis 
by revealing inequalities in the diagnosis, treatment and outcomes of care for 
migrants: compared with the host population, migrants living with HIV were less 
frequently diagnosed (73% vs 84%), received treatment (51% vs 75%) or achieved 
viral suppression (41% vs 68%). A total of 41 countries were unable to report migrant 
data for any stage of the care continuum. In contrast, only three countries were 
unable to report data on any stage of the continuum for the general population, 
highlighting a lack of integration of HIV monitoring for migrants among systems 
for routine data collection (46).
The evidence suggests that a European platform for multicountry data collection 
and analysis, sharing of countries’ policies and practices, and harmonization of 
migrant screening strategies is needed to overcome the heterogeneity in data 
collection and ensure comparability across countries (42). Primary studies concluded 
that, to overcome the lack of recording of relevant health data, a designated 
body with clear responsibility for data coordination, collection, analysis and 
9
dissemination should be set up to harmonize data collection efforts at the level 
of EU/EEA countries (45).
Finally, three studies considered the varying practices of coding migrant status and 
the accuracy of reporting in infectious disease surveillance, and their impact on data 
comparability (11,47,48). One combined a literature review, data analysis and expert 
interviews to compare the migration status indicators used by national surveillance 
systems in six European countries (Denmark, Finland, Germany, the Netherlands, 
Sweden and the United Kingdom) in order to determine the impact of migration 
status on hepatitis B virus infection. The migration indicators used were diverse (47):
• allochtonen (the Netherlands), defined as those who were born outside the 
Netherlands or who have at least one foreign-born parent;
• persons with a migration background (Germany), defined as those who 
have either migrated into Germany themselves or are the second- or third-
generation descendants of migrants;
• foreign background, consisting of foreign-born people with foreign citizenship 
or foreign language as mother tongue (Finland) or a citizen, either foreign-
born or born within the country, and having (i) two foreign-born parents, 
(ii) a foreign citizenship or (iii) asylum seeker status (Sweden);
• immigrants, defined as residents born outside the country (United Kingdom) 
or a person born abroad whose parents both are foreign citizens or were born 
abroad (Denmark); and
• descendants (Denmark), defined as people born in the country whose parents 
are either migrants or descendants with foreign citizenship.
The study concluded that heterogeneity in migration indicators limited the 
comparability of surveillance data across different countries, demonstrating the 
need for harmonized migration status indicators in different notification systems 
(47). A systematic review concluded that collecting data on multiple dimensions 
of migration could favour the disaggregated analysis of migrant health data, 
with infectious diseases used as an example (11). It found that the only variables 
reported by EU/EEA Member States in notification systems to define an incident case 
of a given disease as a migrant were “country of birth” or “country of nationality” 
(citizenship). The study noted a need for further national-level research to explore 
the reasons for the underreporting of migrant status and suggested consensus 
meetings involving disease and migration experts to design a set of core variables 
and indicators to aid comparability. Another review identified several additional 
factors affecting the accuracy of disease reporting (e.g. language, legislation, 
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entitlement to health care, screening for asymptomatic disease). It reported that 
infectious diseases are less likely to be underreported among migrants compared 
with host populations due to incomplete denominator data, which results in 
underestimating the population at risk (48).
2.1.2.2  National level
Three studies considering country-specific infectious disease surveillance were 
conducted in Italy (49–51). Two of these addressed the accuracy and completeness 
of TB surveillance systems, with inconclusive results: while the first study found 
inaccurate estimates of the annual incidence of TB among migrants (analysis period 
of one year) (49), the second concluded that underreporting was significantly greater 
for Italians than for migrants (analysis period of 10 years) (50). A third case study 
from Italy described the initiation of an HIV surveillance network, coordinated 
by the National AIDS Centre. It found that collaboration with clinical centres, 
laboratories and institutional agencies to monitor the genetic diversity of HIV 
strains in Italy is affordable and improves data availability, yet suffers from issues 
of data quality and accuracy (51).
A French case study highlighted the relevance of Marseille’s strategic location 
as a major entry port for international migrants and the importance of the 
city’s participation in regional and international surveillance activities, including 
EuroTravNet (European Travel Medicine Network) and the European Network for 
Tropical Medicine and Travel Health (TropNetEurop) (52). Data collection among 
migrants and other mobile populations is conducted in several tropical medicine 
units in civilian and military hospitals, contributing to improved surveillance efforts 
on infectious diseases such as malaria and dengue (52).
A Swiss case study reported on the improved interpretation of routinely collected 
HIV notification data using a concurrent (permanent) cohort study. It showed 
that analysis of notification data alone can lead to the misinterpretation of overall 
incidence and treatment because data quality is not always sufficient, and information 
on the time from diagnosis to notification is not recorded. The notification systems 
allowed for the establishment of a designated cohort study comprising all incident 
cases and included routinely collected patient-reported data on health service access 
and utilization, prevalence of risk factors and sexual behaviour, disaggregated by 
nationality (53).
Finally, a German case study discussed the operationalization of migration 
classifications in German infectious disease surveillance. Currently (2019), 
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the recommended criterion of country of birth is only routinely collected for TB, 
while notification systems for HIV and syphilis use citizenship data (54). There were 
also concerns over data quality because migration status data were incomplete 
in all three notification systems. The study called for improved harmonization 
of migrant definitions between datasets by including both country of birth and 
citizenship indicators.
2.1.3  Medical records and health service utilization data
Five studies considered medical records and health service utilization data (hospital 
or clinical records in which data are generated on health service utilization at primary, 
secondary or tertiary level) for migrants (9,12,53,55,56). Of the 11 countries in the 
EU that record migrant status in their health service utilization data, five collected 
data on citizenship, one recorded the country of birth and five used both of these 
indicators (9).
Italy and England (United Kingdom) have data quality and completeness issues 
related to coding of migrant and ethnicity categories, which affect the availability 
of disaggregated data (26). One study that quantitatively analysed the agreement 
between hospital records and maternal reporting of mode of delivery in a 
representative sample in the United Kingdom found that a lack of agreement 
was more common for women not born in the United Kingdom (55).
Data quality was reported to be better in the Netherlands and Sweden because of 
the possibility of data linkage with civil registration systems and regular clinical 
audits (26). However, one study found evidence of underrecording of mental 
health problems among irregular migrants in the Netherlands, which affected the 
availability of data (56). For asylum seekers, the gap in availability of health records 
was 13% in the Netherlands, in contrast to 88% in Germany (12).
2.1.4  Subgroup-specific data sources
Five studies considered specific sources of routine data collection for asylum 
seekers and refugees in camp-like medical settings in Germany, Greece and 
Italy (12,57–60). These studies highlighted the importance of keeping digital 
medical records rather than paper-based records to improve data availability on 
general health aspects and medical treatments (57); those specifically related to 
vaccination, hepatitis, HIV and TB; and syndromic surveillance (58). They further 
highlighted the challenge of sustaining data collection in the context of rapidly 
changing policy contexts related to management of reception centres, which 
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leads to the discontinuation of routine data collection (59) and a lack of adequate, 
reliable data for the local planning of health-care services for asylum seekers in 
reception centres (57,59). Even when data collection systems are in place, health 
data recording may be inaccurate due to the documentation practices of health 
workers: a quantitative study in Greek refugee camps that prospectively analysed 
the quality of data capture and adequacy of recorded clinical information found 
that clinical data on syndromes was accurately documented for only 11% of cases 
and that disease severity was largely unknown (60). The authors concluded that 
case records often do not contain all of the information assessed during the 
consultation, despite clinicians anecdotally reporting information that would be 
critical for an outbreak assessment (60). An assessment of the health information 
systems in Germany and the Netherlands found that data availability for specific 
subgroups (e.g. unaccompanied minors, pregnant asylum seekers and refugees, 
victims of torture and violence), determined according to the criteria set out to 
measure capacity gaps, was poor in Germany (100% gap) and somewhat better 
in the Netherlands (63% gap) (12).
2.1.5  Health monitoring surveys
Four studies focused on health monitoring surveys among migrants. Out of 
27 surveyed EU Member States, one study found relevant health monitoring 
data for migrants in only six countries: Belgium, Denmark, France, Italy, Portugal 
and the United Kingdom (9). Limitations of health monitoring surveys among 
migrant populations included low response rates, small sample sizes, a lack of 
multilingual survey instruments and variation in the indicators of migrant status 
used across countries.
In Germany, efforts to represent migrants in health monitoring surveys have 
increased in recent years. A mixed-methods study compared different sampling 
strategies and tested different approaches to recruit migrants into the German 
National Cohort Study (61). It used nationality, name and country of birth to query 
register data to identify people with a history of migration and concluded that 
the combined use of the three indicators may improve identification of migrants 
compared with nationality alone. The register-based approach was compared with 
a community-oriented data collection approach, which required additional human 
and time resources but increased acceptance among participants. The higher 
acceptance rate improved the feasibility of conducting surveys, thus increasing 
the availability of refugee and migrant health data.
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In the Netherlands, health monitoring surveys have grouped first- and second-
generation migrants, while distinguishing between “western” and “non-western” 
migrants (26). Problems were identified in the Dutch health monitoring survey 
relating to internal and external validity2 for migrant populations because these 
tend to be underrepresented (26). A population-based seroprevalence study that 
aimed to better integrate migrant populations identified the following strategies 
to improve data collection among this population: oversampling, multilanguage 
questionnaires and linkage of serological samples to self-reported data (62).
In England (United Kingdom), migrant status (first and subsequent generations) 
and ethnicity are routinely collected in health monitoring surveys, and analysis 
of these data has recently been strengthened by the use of designated sampling 
approaches for migrant populations (26).
2.1.6  Factors affecting the availability and integration of refugee and 
migrant health data in health information systems
The review also identified articles reporting factors that affect the availability and 
integration of data on refugee and migrant health in health information systems, 
at both the political and practical levels.
On a political level, several studies noted the lack of clear national and European 
strategies for collecting migrant health data, resulting in a lack of nationwide datasets, 
differing definitions of migrant and an overemphasis on specific diseases rather 
than comprehensive public health monitoring (9,26,63). For example, Germany 
and the Netherlands had large shortcomings in data collection capacity (75% gap) 
related to specified coordination, planning and policy efforts (12). In some European 
countries, regulatory efforts need to be increased because no data pertaining to 
refugee and migrant health are currently collected (9). In other European countries, 
existing routine data sources on the health of migrants have substantial gaps and 
inconsistencies that could be improved by harmonizing migrant categories and 
including better questions on migrant status (9). Regarding migrant categories 
in use, the existing literature shows that indicators on both country of birth and 
nationality are necessary for high-quality analyses (11,54). In addition, information 
on factors such as length of stay and reason for migration are essential for rigorous 
epidemiological analyses (34,35).
2  Internal validity is the extent to which a study is well conducted regarding procedures and technical 
aspects and external validity is the extent to which findings are applicable or transferable to a broader 
population.
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The available literature showed that countries could do more to learn from each 
other in formulating policy objectives at a European level, which would help to 
increase the comparability and comprehensiveness of European data collection 
instruments for refugees and migrants (9,12,26,45,48,63). Suggested actions included 
designating a body with clear responsibility for European data coordination (9,12,45), 
establishment of a European data platform to aid the sharing of best practices 
(42,43) and achieving consensus with experts in the field on a core set of health 
indicators for refugees and migrants (11).
On an operational level, the availability and integration of systems for routine data 
collection are hampered by poor-quality reporting for migrant subgroups in health 
service utilization data and associated registers and surveillance systems (48,56,60), 
lack of denominator data (44) and lack of specific health monitoring approaches 
to adequately represent migrants in health information surveys (9,26,61,62). 
Poor-quality medical records for migrants may result from inaccurate disease 
reporting, which is influence by factors such as language, legislation, entitlements 
and access to health care, health service utilization patterns, and attendance 
for asymptomatic disease screening (48,56). In addition, a lack of understanding 
among clinicians of the data requirements for epidemiological surveillance could 
reduce the quality of documentation and limit data availability (60). However, since 
underreporting is likely to be worse for host populations, one review recommended 
focusing on improving the existing systems for both host and migrant populations, 
with specific attention paid to underreporting in host populations, as an approach to 
improve epidemiological monitoring (48). Existing surveillance systems for the general 
population could be strengthened towards refugee- and migrant-sensitive health 
information by including the main risk factors for infectious diseases among refugees 
and migrants, such as country of origin, length of stay and history of migration (48).
Health monitoring surveys often fail to adequately represent the health needs of 
refugees and migrants because of low response rates among these populations, 
small sample sizes and a lack of multilingual survey instruments (9,61). Strategies 
to overcome these limitations include oversampling strategies among refugees and 
migrant groups to enable statistically meaningful analyses (9,62) and community-
based recruitment strategies to reduce language barriers and increase response 
rates (61). Overcoming structural barriers to data collection for refugee and migrant 
populations (including fluidity of the patient population, limited participation of 
local and regional authorities, closure of temporary accommodation for refugees 
and the burden of additional data items) requires good coordination with multiple 
stakeholders and is key to ensuring the sustainability and integration of data 
collection efforts (59,60).
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2.2  Studies using routinely collected data
In strategy 2, a synthesis of abstracts from 696 studies (listed in Annex 3) using 
data from health information systems to analyse refugee or migrant health 
found evidence that routine data are systematically collected in only 25 of the 
53 Member States of the WHO European Region (Fig. 2). Most studies were 
identified in Sweden (12.5%), followed by Denmark (8.0%), the Netherlands (7.8%), 
Italy (7.4%), the United Kingdom (7.3%), Spain (6.3%), Germany (5.6%) and 
Norway (5.2%), with less than 5% identified in each of the other countries of the 
WHO European Region. Results for each of the main categories of routine data 
are given in the following sections.
2.2.1  Stage of migration and data collection
Of the 696 studies, 576 (82.8%) captured data for the routine data collection system 
at the post-entry stage of migration. Fifteen studies (2.2%) used data sources for 
which information was obtained at entry to the host countries (e.g. on-arrival 
screening), while only four (0.6%) used data sources capturing data prior to 
departure from the country of origin. Determining the migration stage at which 
data were collected was not possible for 105 (15.1%) studies. In all, 23 of the 53 WHO 
European Region countries conducted post-entry data collection. Considerably 
fewer countries conducted at-entry (n = 9) and pre-entry (n = 4) data collection.
Fig. 2. Number of studies by country (strategy 2)
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Note: total number of studies (1082) includes international studies that are counted more than once depending 
on the number of countries included.
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2.2.2  Geographical scope
More than half of the 696 studies (n = 412, 59.2%) used data collected in nationwide 
systems. Most data sources with national coverage were found in Sweden (22.8%), 
Denmark (14.3%), the Netherlands (11.2%), Norway (8.5%), Israel (6.8%), the United 
Kingdom (5.8%) and Germany (5.6%). In other countries, the figures were all less 
than 5%. About one third of the studies identified in the WHO European Region 
(n = 226, 32.5%) used a data source with subnational scope (i.e. covering one or 
more localities/regions within a country). Most data sources with subnational scope 
were from Italy (19.0%), followed by Spain and the United Kingdom (both 15.0%), 
Sweden (8.4%), Germany and the Netherlands (both 7.1%), and Greece (4.9%), 
with contributions of less than 5% from each of the other countries. The geographical 
scope could not be categorized in 19 (2.7%) studies.
2.2.3  Data analysis period
Of the 696 studies, 108 (15.5%) covered a period of one year or less in the analysis 
of refugee and migrant health; 168 (24.1%) covered a period of more than one year 
to five years, about one fifth covered a period of more than five years to 10 years 
(n = 117, 16.8%) and about one fifth covered more than 10 years (n = 132, 19.0%; 
Table 1). Overall, less than 35% of studies covered a period of five years or longer, 
which might indicate that the availability of longer data periods is limited in many 
countries. Information on the data analysis period was not available in the abstracts 
of about one fifth of studies (n = 154, 22.3%).
2.2.4  Sources of routine data by country
Of the 696 studies, 14.0% (n = 97) used disease-specific registers that included 
refugees or migrants (Annex 3 (1–97)), while only 5.3% (n = 37) used data obtained 
from health monitoring surveys among refugees and migrants (Annex 3 (98– 134)). 
About a fifth of the studies (n = 154, 22.2%) used data linkage strategies to link 
the demographic data of migrants with health and/or health service utilization 
data and socioeconomic variables (Annex 3 (135–288)), and another fifth 
(n = 133,  19.0%) used medical records and health service utilization data to 
assess refugee and migrant health (Fig. 3; Annex 3 (289–421)). Less than one fifth 
(n = 118, 17.0%) used data from notification systems in the context of infectious 
disease surveillance (Annex 3 (50,422–538)), 11.9% (n = 83) used population-
based records (Annex 3 (539–621)), 3.2% (n = 21) used subgroup-specific records 
(Annex 3 (622–642)) and 2.3% (n = 16) used other information (e.g. hospitalization 
data, unemployment) as indicators of refugee or migrant health (Annex 3 (643–658)). 
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Table 1. Data analysis period by country
Notes: studies listed under the heading of Europe include more than one country of the WHO European Region; 
studies listed under the heading of international are comparative international studies from outside Europe that 
include at least one country of the WHO European Region; percentages refer to column percentages.
Heat map colours indicate quintiles of the total number of studies (darkest being highest).
Country <1 year >1 to 5 
years
>5 to 10 
years
>10 years Multiple Not 
specified
Total
n % n % n % n % n % n % n %
Austria 1 0.9 1 0.6 0 0.0 0 0.0 0 0.0 0 0.0 2 0.3
Belgium 2 1.9 3 1.8 1 0.9 2 1.5 0 0.0 0 0.0 8 1.1
Czechia 0 0.0 1 0.6 0 0.0 0 0.0 0 0.0 0 0.0 1 0.1
Denmark 8 7.5 9 5.4 17 14.7 22 16.8 2 10.0 10 6.5 68 9.7
Finland 1 0.9 6 3.6 1 0.9 8 6.1 1 5.0 2 1.3 19 2.7
France 2 1.9 3 1.8 4 3.4 0 0.0 0 0.0 1 0.6 10 1.4
Germany 13 12.1 9 5.4 4 3.4 5 3.8 2 10.0 7 4.5 40 5.7
Greece 2 1.9 2 1.2 3 2.6 2 1.5 2 1.5 8 5.2 19 2.7
Hungary 0 0.0 0 0.0 0 0.0 1 0.8 0 0.0 0 0.0 1 0.1
Ireland 0 0.0 1 0.6 1 0.9 0 0.0 0 0.0 0 0.0 2 0.3
Israel 5 4.7 6 3.6 7 6.0 7 5.3 1 5.0 11 7.1 37 5.3
Italy 8 7.5 24 14.3 13 11.2 8 6.1 0 0.0 9 5.8 62 9.8
Malta 0 0.0 1 0.6 0 0.0 0 0.0 0 0.0 0 0.0 1 0.1
Netherlands 4 3.7 19 11.3 12 10.3 12 9.1 2 10.0 14 9.1 63 9.1
Norway 11 10.3 9 5.4 5 4.3 8 6.1 0 0.0 7 4.5 40 5.7
Poland 0 0.0 1 0.6 0 0.0 0 0.0 0 0.0 1 0.6 2 0.3
Portugal 1 0.9 0 0.0 0 0.0 0 0.0 1 5.0 1 0.6 3 0.4
Republic of Moldova 0 0.0 1 0.6 0 0.0 0 0.0 0 0.0 1 0.6 2 0.3
Russian Federation 6 5.6 3 1.8 0 0.0 1 0.8 0 0.0 12 7.8 22 3.2
Spain 12 11.2 9 5.4 8 6.9 9 6.9 0 0.0 11 7.1 49 7.0
Sweden 9 8.4 27 16.1 19 16.4 28 21.4 5 25.0 27 17.5 115 16.5
Switzerland 5 4.7 5 3.0 1 0.9 5 3.8 1 5.0 3 1.9 20 2.9
Turkey 1 0.9 1 0.6 0 0.0 0 0.0 0 0.0 1 0.6 3 0.4
Ukraine 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 1 0.6 1 0.6
United Kingdom 10 9.3 21 12.5 14 12.1 6 4.6 2 10.0 7 4.5 60 8.6
Europe 4 3.7 6 3.6 5 4.3 6 4.6 1 5.0 19 12.3 41 5.9
International 2 1.9 0 0.0 1 0.9 1 0.8 0 0.0 1 0.6 5 0.7
Total  
(within groups) 107 100 168 100 116 100 131 100 20 100 154 100 696 100
try   
s
WHAT IS THE EVIDENCE ON AVAILABILITY AND INTEGRATION OF REFUGEE 
AND MIGRANT HEALTH DATA IN HEALTH INFORMATION SYSTEMS IN THE 
WHO EUROPEAN REGION?
HEALTH EVIDENCE 
NETWORK SYNTHESIS 
REPORT
18
Specific information on the underlying source(s) of routine data collection was 
not clear in 5.6% (n = 39) of the abstracts, although data were said to be taken 
from one or more routine data collection mechanisms (Annex 3 (471,659–696)).
Population-based records were most frequently used in Sweden, followed by 
Denmark, the Netherlands and Norway (Fig. 3). Medical records and health 
service utilization data were most frequently used to study refugee and migrant 
health in Italy, Spain and Sweden, followed by Israel, the Netherlands and the 
United Kingdom. Studies using health monitoring surveys to assess refugee and 
migrant health were most frequent in Germany, followed by Israel and Sweden. 
Notes: disease-specific registers: clinical case registers for specific diseases; Europe: Europe-wide studies including 
more than one country of the WHO European Region; group-specific records: include records for specific groups 
of refugees and migrants, such as unaccompanied minors and pregnant women; health interview surveys: include 
population-based household surveys, behavioural surveillance surveys and health monitoring surveys; international: 
comparative international studies outside Europe, but including at least one country of the WHO European Region; 
linked: studies reporting data linkage between routine data sources; notification systems: include notification and 
surveillance systems for infectious diseases.
Fig. 3. Number of studies by country and type of data source
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Countries that often use population-based records are also those that most 
frequently apply data linkage strategies (Denmark, Finland, Norway and Sweden; 
65.6% of studies using linked data sources). About 20% of studies using data linkage 
were from Italy, the Netherlands and the United Kingdom, while other countries 
used data linkage considerably less often as a strategy to obtain information on 
refugee and migrant health.
2.2.5  Health outcome assessed by country
Each study using routine data from health information systems reported one 
or more health outcomes, depending on its objectives and analysis. Half of the 
696 studies assessed an infectious disease outcome (n = 348, 50.0%), one fifth 
(n = 140, 20.1%) assessed a noncommunicable disease (NCD) other than 
mental illness and 15.5% (n = 108) assessed a mental health outcome (Figs 4–6). 
Notes: only countries with studies that reported relevant outcomes are included; Europe: Europe-wide studies 
including more than one country of the WHO European Region; hepatitis: includes hepatitis A, B and C; 
international: comparative international studies outside Europe but including at least one country of the 
WHO European Region.
TB Hepatitis infectionsHIV OtherMalaria
Fig. 4. Number of studies on infectious diseases using routine data by country
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Other reported health outcomes were maternal health data (n = 75, 10.8%), mortality 
data (n = 56, 8.0%), suicide (n = 23, 3.3%), injuries (n = 18, 2.6%) and other health 
outcomes (n = 85, 12.2%; Fig. 7).
Most studies on infectious diseases were identified in Italy and the United Kingdom, 
followed by cross-national European studies and then studies from Germany, 
Greece, the Netherlands and Spain. Studies on NCDs other than mental illness 
primarily came from Denmark, Italy, the Netherlands and Sweden. Mental health 
outcomes were also most frequently studied in Denmark and Sweden, followed by 
France, Israel, the Netherlands and Norway. Maternal health outcomes, as well as 
general mortality and suicide, were primarily studied in Sweden. Studies on suicide 
were performed in only nine countries, indicating data gaps in other countries. 
Similarly, studies on injuries were identified in only 10 countries.
Fig. 5. Number of studies on NCDs using routine data, by disease category and 
country
Cardiovascular diseases DiabetesCancer Other NCDs
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Notes: only countries with studies that reported relevant outcomes are included; Europe: Europe-wide studies 
including more than one country of the WHO European Region.
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Fig. 6. Number of studies on mental health problems using routine data, by disease 
category and country
Notes: only countries 
with studies that 
reported relevant 
outcomes are included; 
Europe: Europe-wide 
studies including more 
than one country of 
the WHO European 
Region; general mental 
health: includes 
general measures of 
well-being or unspecific 
distress; other mental 
health issues: includes 
other specific mental 
health diagnoses (e.g. 
post-traumatic-stress 
disorder, eating 
disorders).
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Fig. 7. Number of studies on further health outcomes using routine data, by country
Notes: only countries 
with studies that 
reported relevant 
outcomes are included; 
Europe: Europe-wide 
studies including more 
than one country of 
the WHO European 
Region; international: 
comparative 
international studies 
outside Europe but 
including at least one 
country of the WHO 
European Region.
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2.2.6  Migrant categories by country
The category of migrants most frequently used by the 696 studies was foreign 
born (defined by country of birth; n = 428, 61.5%), followed by groups characterized 
by their residence status or experience of displacement (such as refugee and/or 
asylum seeker; n = 143, 20.5%). A total of 129 studies (18.5%) did not further specify 
the migrant group.
Country of birth was the variable most widely used to identify migrants in routine 
data sources in Denmark, Finland, Germany, Greece, Israel, Italy, the Netherlands, 
Norway, Spain, Sweden and the United Kingdom and in European (cross-national) 
studies. This variable was used in studies from all countries except for Austria and 
Ukraine. Studies from 17 countries used categories related to residence status or 
experience of displacement.
2.3  Sources of routinely collected data
This part of the evidence synthesis is based on the abstracts of 696 studies using data 
from health information systems to analyse refugee or migrant health (Annex 3). 
Of these, 324 (46.6%) gave the name of the system they had used for routine data 
collection system, with a total of 242 different routine data sources: 14 (5.8%) were 
international, 168 (69.4%) were national and 58 (24.0%) were regional. Most of 
the routine data sources were reported in studies from Sweden (n = 42, 17.4%), 
Italy (n = 33, 13.6%), Denmark (n = 28, 11.6%) and the United Kingdom (n = 21, 8.7%). 
A full list of the 242 health information systems is given in Annex 4.
The sources of routine data were found to vary according to the health outcome 
studied. For example, linked systems and disease-specific registers commonly 
provided data on NCDs, all-cause mortality and maternal health, while mental 
health outcomes were particularly prominent in studies using data collected 
through health monitoring surveys (Fig. 8). Notably, studies based on data from 
notification systems for infectious disease did not analyse other conditions, 
suggesting a lack of data availability on comorbidities or other relevant health 
outcomes among refugees and migrants suffering from infections.
2.3.1  Population-based records
Population-based records were most frequently used in Sweden (37.3% of studies 
using population-based records) (Case study 1), followed by Denmark (12%), 
the Netherlands (9.6%), Norway (8.4%), the United Kingdom (6.0%) and Israel (6.0%), 
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especially for the analysis of maternal health issues, mortality and general mental 
health problems. A total of 50 unique population-based data sources (20.7% of the 
242 data sources) were identified in the reviewed studies (see Annex 4).
Case study 1. The Danish Civil Registration System
The Danish Civil Registration System was launched in 1968 to replace paper-
based records in municipal registers with electronic records in a centralized 
civil register (33). All people born of a mother already registered in the Civil 
Registration System or who reside legally in Denmark for three months or 
more are registered in the Civil Registration System with a unique Civil Personal 
Registration (CPR) number. The CPR number is similar to those of other Nordic 
countries, consisting of a 10-digit person identifier. A total of 9 484 792 individuals 
were included in the Civil Registration System in January 2014 (32): information 
Fig. 8. Mosaic graph of sources of routine data and health outcomes
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included the address, date and place of birth, country of citizenship, kinship, 
civil status and registered partnerships. This information can be accurately and 
cost-effectively linked via the CPR number to a wide range of individual-level 
registers (several of these registries were identified in an analysis of reference 
32 but are not included in Annex 4): the Danish General Practice Database  
(since 2007), Danish Cancer Registry (since 1943), Registry of Causes of Death 
(since 1943), National Patient Registry (since 1977), Danish Breast Cancer 
Cooperative Group Registry (since 1977), National Prescription Database  
(since 1995), Danish Pathology Database (since 1997), Western Denmark Heart 
Registry (since 1999) and the Danish Stroke Registry (since 2003). Further linkages 
are possible to the Danish Central Psychiatric Research Register, the Danish 
National Health Service Register, the Danish Injury Register and the Danish 
Medical Birth Register. Therefore, many studies use the system as a tool in 
epidemiology, including in refugee and migrant health research, to perform 
follow-up studies, assess all-cause mortality and establish comparison cohorts, 
family cohorts, control samples or random samples for population surveys.
2.3.2  Medical records and health service utilization data
The evidence synthesis found that medical records or health service utilization 
data were most frequently used in Italy (15.8%), Spain (15.0%) (Case study 2) and 
Sweden (14.3%), especially in the analysis of maternal health issues, infectious 
diseases and general mental health outcomes. Overall, 25 (10.3%) national and 
15 (6.2%) subnational medical records or health service utilization data systems could 
be identified from the reviewed studies among all 242 data sources (see Annex 4).
Case study 2. Use of electronic medical records in refugee and migrant health 
research in Spain
A total of 20 studies from Spain on refugee and migrant health used electronic, 
facility-based medical records, indicating that this country predominantly 
relies on such records for migrant health data. Most of the studies were on 
infectious diseases, included between one and four facilities and covered time 
periods of up to two years (64–74).
In the Aragón region, all medical data of patients registered in the public 
health-care sector are coded and stored in a central electronic medical records 
Case study 1 contd
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system (OMI©: Computerized Medical Office). After an official request and 
authorization, researchers are allowed to conduct research using population-
based, regional samples. Demographic variables routinely recorded in the 
system include nationality, which has been used as a variable to assess the 
health of migrants (75–77). Three studies included in the evidence synthesis 
have used this data source: they address overall morbidity, primary care 
utilization and mental health in migrant populations (75–77). In addition, 
data obtained from OMI© can be linked with other databases through the 
Aragonese Identification Code. Two studies following this approach linked 
medical data obtained from OMI© to either a regional prescription register 
with the health insurance database (77) or the central medical database of 
the regional health service (76).
2.3.3  Health monitoring surveys
Studies utilizing health monitoring surveys as a data source were most common 
in Germany (18.0%) (Case study 3), followed by Israel (13.5%) and Sweden (10.8%); 
they mainly focused on the analysis of HIV, TB and mental health problems. 
A total of 31 (12.8%) individual health monitoring surveys were identified among all 
242 data sources (Annex 4) in the 696 reviewed studies (Annex 3).
Case study 3. Health monitoring surveys in Germany
In Germany, three key data collection surveys were used to monitor the health 
status and health system accessibility for the population: the German Health 
Interview and Examination Survey for Adults (DEGS), the German Health 
Interview and Examination Survey for Children and Adolescents (KiGGS) and 
the European Union Statistics on Income and Living Conditions (EU-SILC; 
implemented in Germany as the Living in Europe survey). The first two were 
carried out by the Robert Koch Institute and the third was conducted by the 
Federal Office for Statistics (Statistisches Bundesamt).
DEGS is the main health monitoring survey in Germany; it has been conducted 
since 2008 and is based on previous similar health monitoring approaches 
for the German population. In its current form, it is conducted approximately 
every four years and combines health interviews (general health, medications, 
nutrition, anamnesis), using in-person, postal and telephone interviews, 
Case study 2 contd
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with health examinations (laboratory tests, physical examination) (78,79). 
The survey has a response rate of 42% and shows good representativeness 
when compared with the general population (79). The general self-completion 
health survey includes questions to capture data on self-rated health status, 
chronic illnesses, health risks, participation in health promotion activities 
and health service utilization. Migrant status is captured using multiple 
indicators on citizenship, country of birth of parents, first language and 
length of residence in Germany (14). The questionnaire has been translated 
into four languages (English, Russian, Serbo-Croatian and Turkish), but so 
far the survey has been able to generate reliable data only for specific migrant 
groups (e.g. Turkish migrants). Therefore, recent initiatives have tried to 
improve the integration of migrants into existing health monitory surveys (80).
KiGGS additionally captures residence status, enabling a distinction to 
be made between migrants with secured residence status and those with 
insecure status (temporary refugee protection, toleration or asylum seeker 
status). The availability of a public-use file of the data to researchers and the 
variety of included health outcomes make it a valuable resource for scientists 
and policy-makers to monitor the health status and access to health care 
for migrants. The evidence synthesis identified three studies that used the 
survey data: one on access to physical therapy services (81), another on the 
prevalence of osteoporosis (82) and a third on subjective health status (83). 
Four further studies used KiGGS to examine the prevalence of hepatitis B 
(84), varicella (85) and the use of herbal medicinal products (86) among 
migrant children and adolescents, and inequalities in health and access to 
health care between children with insecure residence status and those with 
secured status (87).
2.3.4  Disease-specific registers
In the 696 reviewed studies, disease-specific registers were most frequently used as 
a data source in the Netherlands (13.4%), Sweden (11.3%), Denmark (10.3%) and Italy 
(9.3%). In addition, 15.5% of those studies using disease-specific registers analysed data 
from multiple European countries. The health outcomes analysed most frequently 
were NCDs (diabetes, cancer and cardiovascular disease) and infectious diseases 
(especially HIV) (Case study 4). A total of 38 (15.7%) different disease-specific registers 
were identified among all data sources (Annex 4) in the reviewed studies.
Case study 3 contd
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Case study 4. Cancer registers in the WHO European Region
Cancer registers were the most common type of disease-specific register used 
by studies on migrant health in the WHO European Region. A survey study 
in 2007 identified several European cancer registers that routinely collect and 
integrate migrant status but noted that, although the data were available 
and allowed disaggregation, the registers were rarely used in epidemiological 
research (88). The evidence synthesis identified a total of nine empirical 
studies using information from cancer registers: four from Sweden (89–92), 
two from Israel (93,94), one from Germany (95), one from the Netherlands 
(96) and one from Norway (96).
Most of these registers cover cancer in general (the German Centre for Cancer 
Registry Data at the Robert Koch Institute, the Israel National Cancer Registry, 
the Netherlands Cancer Registry and the Cancer Registry of Norway), while 
others focus on a specific type of cancer (the Swedish Melanoma Registry 
and the National Quality Register on Prostate Cancer of Sweden) or other 
aspects, such as familial risks (the Swedish Family-Cancer Database (90,91)). 
Datasets from these registers are available to researchers upon request, but the 
availability of data on migration variables differs between registers.
The Netherlands Cancer Registry routinely includes data on country of birth 
within its datasets, while the Israeli counterpart retrieves such data from the 
national population register via a personal identifier (93,94,96). In Norway 
and Sweden, the national cancer registers do not include sociodemographic 
data beyond age, sex and place of residence. However, the data can be linked 
to datasets available from other population-based registers such as Statistics 
Norway or the Swedish Population Register via a personal identification number 
(89–92,97). Data in Statistics Norway include country of birth, migration 
status and age at immigration and in the Swedish Population Register include 
country of origin and date of immigration; consequently, their datasets provide 
important variables related to migration (97).
In contrast, German cancer registers are fragmented, regionally governed and 
do not include data on country of birth or other variables related to migration, 
making their data less readily available for migrant health research. In the 
only German study identified in the review to use data from a cancer register, 
researchers used a cohort of re-settlers from the former Soviet Union that was 
established in 1990 based on information on country of birth obtained from 
local population registers. Records from this cohort were then linked to the 
cancer register through name recognition (95).
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2.3.5  Notification and surveillance systems for infectious diseases
Of the 696 reviewed studies, data from notifications systems for infectious diseases 
were most frequently used in studies from the United Kingdom (21%), followed by 
the Netherlands (13.4%), Italy (7.6%), Germany and Spain (both 6.7%) for the analysis 
of hepatitis, HIV, malaria and TB, infections. In addition, around 8% of reviewed 
studies used notification data from multiple European countries (Case study 5). 
A total of 61 different notification systems for infectious diseases in WHO European 
countries could be identified in the reviewed studies, comprising 25.2% of the 
242 identified sources of routine data collection (Annex 4).
Case study 5. TropNetEurop
TropNetEurop is currently the largest European network on imported infectious 
disease surveillance, involving 75 specialized clinical sites in 18 European 
countries and focusing on infectiology and tropical medicine. TropNetEurop 
is coordinated by the Department of Medical and Diagnostic Services of the 
Swiss Tropical and Public Health Institute in Basel and is structured into 
three committees: a steering committee, a network committee and a research 
committee. Its objectives are to establish and sustain a sentinel surveillance of 
imported infectious diseases in Europe and to identify emerging infections in 
returning international travellers, refugees, migrant workers, business travellers 
and foreign visitors. TropNetEurop provides a platform for collaborative research 
on travel-related infectious diseases for evidence-informed recommendations 
and strategy development in European countries (98,99). It collects data from 
patients with travel or migrant history who have presented for treatment at 
one of the participating clinical sites in Europe.
This evidence synthesis identified four studies using surveillance data from 
TropNetEurop. Two studies analysed features of incident schistosomiasis 
cases in Europe regarding patient origin, type of travel and potential risk 
factors associated with infection (100,101). Another two further examined the 
epidemiological characteristics of migration-related malaria cases in Europe 
(102,103). However, surveillance via specialized clinics and departments for 
infectious diseases entails limited external validity for the overall population 
of refugees and migrants because of the facility-based nature of the data, 
which rely on referrals and self-referrals (entailing the possibility of hospital 
bias throughlack of population-level data and samples).
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2.4  Overall evidence on refugee and migrant 
health data
The combined evidence synthesis found that research on the availability and 
integration of refugee and migrant health data is fragmentary across the WHO 
European Region. Most studies assessed specific data collection sources, diseases 
or aspects of health data. Only very few studies focused on more than one data 
collection category or on the health information system as a whole (9,12,26). 
Even less evidence was found on data quality (a crucial aspect of availability), 
integration of systems and policy initiatives to strengthen data collection for 
refugees and migrants.
The evidence also showed that even when refugees and migrants are formally 
included in health monitoring surveys, proactive strategies are required to adequately 
reflect their health concerns, including the accurate translation of survey instruments 
into multiple languages, specific sampling approaches and innovative fieldwork 
approaches (9,14,26,61). Strategies identified to include refugees and migrants in 
health monitoring surveys comprised community-based approaches to recruitment, 
identification of individuals in population-based registers, oversampling and tailored 
sampling approaches, and multilingual survey techniques (9,26,61,62). These are 
consistent with existing research and guidelines on the inclusion of refugees and 
migrants in national health monitoring approaches (14,15). 
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3. DISCUSSION
3.1  Strengths and limitations of the review
The main strength of this review is its comprehensive approach to the analysis 
of health information systems. The inclusion of both empirical studies on health 
information systems and studies using data from such systems provides an overview 
of the research landscape, complementing previously conducted reviews in this 
area (9,11). The blend of narrative and quantitative synthesis allowed conclusions 
to be drawn on the availability and integration of refugee and migrant health data, 
either from studies directly focused on this question or as deduced from research 
using existing data sources across the WHO European Region. The review identified 
more than 240 data sources for refugee and migrant health, which can be used as 
resources for future studies. While insights were gained into data collection systems 
and country practices analysing refugee and migrant health, it is important to note 
that a cross-national assessment of health information systems would be better 
suited to assess the availability and integration of data. Nevertheless, the review 
provides a comprehensive foundation for future undertakings.
The strict definitions of refugees and migrants used in this report (Annex 2) 
excluded studies focused on ethnicity. This may have led to the exclusion of 
studies and data sources for refugee and migrant groups, as studies from some 
countries (e.g. the Netherlands) appear to use these terms interchangeably to 
refer to both migrants and to non-ethnic Dutch people. The differentiation of 
ethnicity and migration is very important and has been a matter of controversy 
(33,104,105). Several papers recommended coding for ethnicity alongside migration 
(or migration status alongside ethnicity) so as to distinguish the effects of each 
(9,33,104), as capturing these variables for health monitoring purposes has different 
objectives (e.g. measurement of inequalities in health attributable to discrimination 
based on ascriptive factors and physical appearance vs inequalities attributable to 
pre-, peri- and post-migration factors).
This report is based on a review of 41 full-text articles on health information systems, 
but another 696 studies using data from routine data sources were included in 
the synthesis based on their abstracts only in order to keep the amount of work 
manageable. This approach is commonly used in bibliometric studies (106) but 
entails the possibility of misclassification, especially in the migration stage in 
which data are collected and the migrant groups categorized. However, the risk of 
misclassification in other primary or secondary outcomes was low because only 
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a few studies did not provide these details in the abstract (5% or less). The review 
approach provided sufficient information to judge the use of routine data sources, 
the geographical scope and type of system, the available health outcomes and 
the data analysis periods. It did not, however, allow for an in-depth analysis and 
mapping of how refugee and migrant groups were specifically defined, especially 
for terms such as refugee, which can be used in both the colloquial and legal senses.
The use of scoping review methodology means relevant studies may have been 
missed. Searches were conducted in English and Russian (and included studies 
in English, German and Russian), and so studies, national documents, guidelines, 
standardized operating procedures and manuals detailing the procedure for data 
collection, storage and dissemination in other languages of the 53 Member States 
may, therefore, have been missed. Moreover, countries not represented in this report 
may have captured data on refugee and migrant health in their health that have not 
been published. However, the aim of this review was not to give a complete picture 
but rather to explore the patterns, gaps and approaches used for data collection.
3.2  Availability and integration of refugee and 
migrant health data
Overall, evidence found in the review was geographically biased towards the 
Scandinavian and central European countries for routine data collection and towards 
western and southern European countries for infectious disease surveillance. 
Very little information was found on data collection mechanisms for refugees and 
migrants in eastern Europe and central Asia. The literature was strongly focused 
towards evidence on routinely collected secondary data and infectious disease 
surveillance, with much less information found on important data collection 
mechanisms such as health monitoring surveys and health service utilization data. 
Furthermore, notification systems for infectious diseases were disease centred, 
poorly integrated and often lacked data on comorbidities or other relevant health 
outcomes. Overall, longer time periods were analysed predominantly by studies in 
countries with nationwide population registries (indicating good data availability), 
while single and scattered time frames were more often found in studies relying 
on fragmented health information systems, indicating limitations in availability 
of time series data on refugee and migrant health.
Numerous factors were shown to affect the availability and integration of refugee- 
and migrant-sensitive data in health information systems operating at both regional 
and national levels in countries across WHO European Region.
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3.2.1  WHO European Region level
Within the WHO European Region, countries could benefit by increased collaboration 
to identify potential strategies, build partnerships, harmonize indicators and 
promote the sharing of best practices as they move towards refugee- and 
migrant-sensitive health information systems (9,12,45,48,63). Differing definitions 
of migrant throughout the health information systems limit the potential for 
comparisons of data across countries of the Region (1,9,26,44,47). Furthermore, 
the binary classification of migrant/non-migrant substantially limits the analysis 
potential for this highly heterogeneous population and reduces the validity of 
the overall conclusions of any analysis on health and access to health care (13). 
Therefore, routine data collection could benefit from including multiple migration 
indicators to capture country of birth, nationality, length of residence and legal 
status (11,14,15,48,54,107). These indicators should distinguish between refugees/
migrants and their offspring (often referred to as second- or third-generation 
migrants), for example by considering both country of birth and nationality. Health 
risks are likely to vary substantially between these groups (33,107), so ethnicity 
categories that fail to consider migration status and length of stay can hide large 
within-group variations in outcomes. To avoid discouraging individuals from 
seeking health care through fear of stigmatization or deportation, the migration 
indicators should ideally not be captured at the point of care but rather made 
available through linkage of systems or other routinely collected indicators for 
monitoring purposes (26,33,36).
Initiatives to improve refugee- and migrant-sensitive systems for routine data 
collection on specific issues exist throughout the EU/EEA, but stronger collaboration, 
for example by designating a body responsible for coordinating data collection 
efforts (48), could ensure that the lessons learned are integrated into systematic 
improvements throughout the Region. As the lead public health agency and with 
extensive technical expertise in designing and strengthening health information 
systems at the regional and national levels, WHO is well positioned to take a 
coordinating role. Initiatives could incorporate the important ethical considerations 
related to gathering, storing, analysing and disseminating data on refugee and 
migrant health. It is important to note that data disaggregated by residence or 
migration status can help public health monitoring and planning of services but 
may also be misused for political stigmatization campaigns against refugees and 
migrants. Attempts of migration authorities to inappropriately access health 
data have been documented (2); therefore, the health sector would benefit from 
establishing effective legal, technical and political measures to safeguard sensitive 
health data against (mis-)use for migration policy purposes. This is particularly 
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relevant and salient for data linkage approaches of the type where immigration 
registers are used to determine denominators and establish links to health and/
or vital records. A coordinating body at the level of the WHO European Region 
could guide Member States while implementing such measures and provide a 
platform to share best practices and experiences from other countries.
More cross-country research is needed to (i) provide a more comprehensive picture 
of the availability and integration of data on refugee and migrant health in health 
information systems across the Region (12) and (ii) explore whether the identified 
policy strategies can strengthen existing data collections systems and provide a 
blueprint for the establishment of new systems (9). Regular performance monitoring 
of health information systems (12) is needed because these complex and adaptive 
systems may undergo rapid change. Germany provides a pertinent example: while 
recent literature confirms that the availability and integration of refugee health 
data in most routine data sources are limited (108), considerable progress has been 
made in specifically established systems for routine data collection (e.g. among 
refugees and asylum seekers using real-time surveillance based on electronic 
medical records (109), targeted health monitoring surveys (110) or longitudinal 
socioeconomic household surveys including health data (111)).
3.2.2  National level
There is potential for all countries of the WHO European Region to strengthen their 
health information systems for the collection of refugee and migrant health data. 
Even in systems without centralized population registers, national data collection 
efforts could be improved by streamlining migration indicators and including 
multiple relevant indicators in all datasets, allowing for linkage between relevant 
datasets and ensuring improved data quality through stronger collaboration on 
the issue of migrant health between the government, institutions, medical facilities 
and clinicians.
The review found a strong focus on studies using secondary data, which are often 
limited by a lack of sociodemographic information, individual life experiences 
related to the migration trajectory and self-reported health data (28,33). Lack of 
information in these areas mean that gaps in current service provision cannot be 
identified and services cannot be planned accordingly. A more complete picture 
of refugee and migrant health could be obtained by collecting data in both health-
care facilities (through high-quality medical records) and among the population 
(e.g. through health monitoring surveys) (9,26,33).
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Although proactive strategies to include refugees and migrants in health monitoring 
were identified, health monitoring surveys represented only a small proportion 
of the included studies using data collection systems for the analysis of refugee 
and migrant health. There is, therefore, an immense potential to scale up the use 
of surveys with refugees and migrants as part of routine health monitoring in 
Member States of the Region (9,26). Inclusion of these populations in national 
health monitoring surveys via effective recruitment, sampling and data collection 
mechanisms is crucial to monitor their long-term health status and health 
service needs.
The ability of routine data to provide information on continuity of care and long-
term trends also needs to be harnessed. Only around a third of the identified 
studies using routine data reported results for periods of over five years, and these 
data primarily came from centralized data collection systems. The potential of 
these data systems could be further exploited, for example by enabling health 
service utilization data from medical records to be linked to migrant registers 
in population records (which are usually maintained by ministries of interior 
or migration authorities, including for non-nationals). Data linkage was most 
frequently observed in Scandinavian countries. However, several countries with 
decentralized health systems that do not have population-wide health registers 
(e.g. Germany, Israel, Italy, the Netherlands and Spain) had used a data linkage 
approach to overcome the fragmentation of their health information systems by 
linking health data with indicators of refugee or migrant status.
Finally, the existing evidence indicates a need to overcome the factors that 
negatively affect the quality of routine data (48,56). Quality issues that specifically 
affect migrants were noted in health service utilization data, which forms the basis 
of registers and surveillance. Furthermore, incomplete recording of diagnoses 
specifically affects refugees in reception centres and irregular migrants in primary 
care settings. The review found evidence that strong collaboration between state 
institutions, clinicians and management, a sound documentation infrastructure, 
and an understanding among all actors of the importance of documentation are 
needed to ensure high-quality data (59,60). A whole-system approach to health 
information systems is required, acknowledging that factors limiting health system 
accessibility for refugees and migrants (e.g. language barriers, financial barriers, 
legislation or restricted legal entitlements) will also impede the collection of 
comprehensive, high-quality data.
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3.3  Policy considerations
Based on the findings of the review, the main policy considerations for the WHO 
European Region are to:
• facilitate the harmonization of indicators and definitions of refugee and migrant 
status in health information systems in the WHO European Region to mitigate 
challenges in cross-border comparability due to heterogeneous definitions;
• designate a supranational body to be responsible for governance, leadership 
and oversight of data collection on refugee and migrant health to foster better 
coordination, cross-country exchange and learning, as well as harmonization of 
data collection strategies (including data quality, integration and protection); and
• regularly monitor the performance of European health information systems 
regarding the availability and integration of refugee and migrant health data 
using appropriate assessment tools.
The main policy considerations for improving health information systems at 
country level are to:
• strengthen existing health information systems for the general population 
because this is also likely to improve the availability of data on refugee and 
migrant health;
• integrate key data elements related to refugees and migrants (e.g. country 
of birth, nationality, length of stay, reason for migration) into existing data 
collection systems to facilitate stratified data analysis, identify at-risk subgroups 
and ensure cross-border comparability;
• establish and/or strengthen a tailored, proactive approach to data collection 
for refugees and migrants that addresses the difficulties in accessing these 
populations, their limited access to health care, their language barriers and 
the small sample sizes;
• utilize and scale up national health monitoring surveys to effectively integrate 
refugees and migrants and facilitate better linkage of survey data with civil/
vital registration data; and
• establish and/or strengthen data linkages across records (e.g. population 
registers, facility-based records and household surveys) in order to:
 – maximize the available health information, particularly in countries 
where refugee and migrant health data are not routinely collected due to 
decentralized health information systems and lack of civil registrations; and
 – generate comprehensive information on refugee and migrant health by 
combining information on health service utilization and migration status.
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4. CONCLUSIONS
Data on refugee and migrant health are routinely collected in less than half of 
the 53 Member States of the WHO European Region. The sources of routinely 
collected data are diverse and the integration of routine data into national health 
information systems appears limited, except for population registers, notification 
systems and medical records in a few countries. The availability of health data for 
refugees and migrants could be improved by increasing their inclusion in health 
monitoring surveys via innovative mechanisms for recruitment, sampling and 
data collection, as well as via data linkage in countries with decentralized and 
fragmented health systems. The review confirmed that varying definitions and 
indicators of refugee and migrant groups hamper the comparability of findings 
between studies, countries and time periods. Research on health information 
systems in the context of refugee and migrant health is patchy and focuses on 
a few data sources or specific diseases. In general, current research efforts fail to 
consider national or European health information systems as a whole. This could 
be remedied by performing regular cross-country and regional assessments of 
the availability and integration of refugee and migrant health data into health 
information systems to generate comparative information for all 53 Member States. 
Although this report provides important policy considerations, countries interested 
in improving the availability and integration of refugee and migrant health data in 
their health information systems should consider that there is no one-size-fits-all 
approach. Instead, strategic improvements to the existing framework are the key 
to developing migrant-sensitive health information systems.
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ANNEx 1. SEARCH STRATEGY
Databases and websites
Seven academic databases were searched on 3 December 2018 for peer-reviewed 
literature in English published between January 2000 and December 2018 on the 
availability and integration of health data for refugees and migrants into health 
information systems in the WHO European Region: Bielefeld Academic Search 
Engine, Cochrane Library, Cumulative Index to Nursing and Allied Health Literature, 
Health Services Research, MEDLINE (via PubMed), Science Direct and Web of 
Science Core Collection. Three additional searches by two Russian-speaking 
members of the review team were performed between 16 January and 30 January 
2019: Bielefeld Academic Search Engine, eLibrary.RU and Russian Citation Index.
A complementary search for grey literature in English was conducted in March 2019 
in Google Scholar and Health Evidence databases using shortened and modified 
search terms. The Annual Reviews, European Centre for Disease Prevention and 
Control, Health Policy Reference Centre, Health System Evidence, International 
Organization for Migration, Migrant Integration Policy Index and Migration Health 
Research Portal were hand-searched for relevant articles and additional websites 
were hand-searched to obtain supplementary case studies on selected routine 
data sources.
Study selection
Inclusion criteria
The general inclusion criteria were:
• published in English, German or Russian•  focused on refugees or migrants as the study population• focused on at least one of the 53 Member States of the WHO European Region• published from January 2000 to December 2018.
These criteria were piloted and iteratively refined to create two complementary 
strategies to select, review and synthesize relevant studies: strategy 1 focused on 
studies reporting evidence on health information systems and strategy 2 on studies 
using routine data.
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In strategy 1, abstracts and titles of studies were screened in tandem for general 
eligibility and the following additional criteria:
• studies that directly reported the availability and integration of data on refugee 
and migrant health in health information systems; and
• studies based on scientific evidence derived from a quantitative, qualitative, 
case study or literature review method (or a combination of these).
Studies meeting these criteria were included for full-text review and synthesized 
narratively after systematic data extraction.
In strategy 2, abstracts were screened to identify:
• primary research studies or outbreak reports with a quantitative method 
using data from health information systems; and
• studies on any health outcome among refugees and migrants that:
 –  used information from one of the defined data collection categories as 
the main underlying data source; or
 –  collected primary data embedded or integrated into a system for routine 
data collection (e.g. in the scope of a national health monitoring survey).
Exclusion criteria
The exclusion criteria for both strategies were:
• reports with an undefined population or no specific mention of migrant or 
refugee populations in their abstracts;
•  reports focused on ethnicity or travellers without clear reference to refugees 
and migrants;
•  studies based on primary data with one-off data collection efforts (e.g. cross-
sectional and cohort studies that did not use routinely collected data);
•  longitudinal studies conducted for a fixed period of time purely for research 
purposes;
•  studies that formally fulfilled the inclusion criteria but failed to contain any 
important information (as agreed by at least two reviewers);
•  case studies;•  clinical case series;•  conference proceedings;•  no full-text available (strategy 1) or no abstract available (strategy 2); and•  geographical location of study not specified in the abstract (strategy 2).
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Screening and data management
Publication details of the identified documents were collected in Endnote X8 
(Clarivate Analytics) and converted to an Excel file for selecting eligible citations. 
Duplicates were removed automatically and/or manually. In both strategies, article 
selection was independently conducted by at least two authors, with discrepancies 
resolved by discussion between at least two reviewers. Peer-reviewed literature in 
Russian was assessed by a Russian-speaking colleague (AT) in consultation with 
another member of the review team (SR/RJ/LB).
Of the 9357 titles and abstracts screened from peer-review literature after removal 
of duplicates, 776 were fulfilled the general eligibility criteria: of these, 76 fulfilled 
the additional criteria for strategy 1 and 696 fulfilled the additional criteria for 
strategy 2 (Fig. A1.1).
Data extraction and evidence synthesis
Data extraction was guided by pre-defined primary and secondary outcomes.
Primary outcomes were:
•  availability of refugee and migrant health data in health information systems; 
and
•  integration of data sources covering refugee and migrant health (if any) within 
national health information systems.
Secondary outcomes were:
•  type of data source, based on the data collection categories in the framework 
of the WHO Health Metrics Network (1);
• types of data (domains, entities, health issues);•  definition of migration;•  stage of migration;•  geographical level (international, national, regional);•  time period covered;• actors involved in the data collection process;•  policies, arrangements and mechanisms for data collection on migrant 
health; and
•  resources for data collection (financial, physical, administrative, human).
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Fig. A1.1. PRISMA flowchart
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In strategy 1, full-text screening of the 76 articles reporting evidence on the 
availability and integration of refugee and migrant health data in health information 
systems identified 41 that directly reported aspects relevant to the review question. 
These were included in a narrative synthesis approach to extract and present the 
available evidence on the state of data collection on refugee and migrant health (2). 
For this, the type of data source, study design, research aim and main findings of 
each study were first recorded in a data extraction sheet. The articles were then 
organized by the type of data source and grouped into major themes by at least 
two members of the review team (KB/LB/RJ) in order to identify the relationships 
between studies, assess the strength of the results and judge the relevance for 
answering the review question.
Strategy 2 yielded a high number of studies using data from health information 
systems (n = 696). To balance academic rigour against the feasibility of managing 
and reviewing such a large body of literature, bibliometric research methodologies 
were applied to perform a quantitative synthesis of information provided in the 
abstracts. Bibliometric literature review is considered an efficient method for gaining 
an understanding of themes in areas with a large number of publications (3). 
The evidence synthesis did not aim to assess the quality or content of the studies 
themselves but instead to understand on a meta-level which routine data sources 
have been used to study refugee and migrant health. Relevant information in the 
following categories was systematically extracted from the 696 abstracts using 
structured spreadsheets:
•  source of routine data:
 –  data system;
 –  country;
 –  type of data source (categorized according to the WHO Health Metrics 
Network: population-based records, medical records, health interview 
surveys, disease-specific registers, notification systems, group-specific 
records, data linkage approaches, data sources that do not fit into these 
categories, unspecified);
 –  type of migrant (country of birth, residence status including refugees 
and asylum seekers, other);
 –  migration stage for data collection (pre-entry, upon entry, post-entry, 
unspecified);
 –  geographical scope of the data source (international, national, subnational, 
unspecified); and
 – data analysis period (one year or less, over one year to five years, over five 
years to 10 years, over 10 years, multiple time periods, unspecified); and
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• health condition:
 – infectious diseases (bacteria, virus, parasites, fungi, no agent specified);
 –  NCDs and chronic diseases (cardiovascular disease, cancer, respiratory, 
diabetes, allergy, other);
 –  mental disorders (cognitive disorders, mood disorders, anxiety disorders, 
personality disorders, substance-related disorders, sexual disorders, 
psychotic disorders, developmental disorders, general distress/well-being);
 – maternal health;
 –  health risks;
 – mortality;
 –  injuries; and
 –  health service utilization.
This information was converted into binary codes, with country as the unit of 
analysis, and then summarized quantitatively by preparing tables of absolute and 
relative frequencies. Heat maps or bar charts were then prepared using the following 
variables: information on data source; health conditions; number of studies by 
country; geographical scope by country; data analysis period by country; type of 
routine data source by country; health outcomes by country; and type of migrant by 
country. The main findings of the heat maps are presented as a narrative summary.
Search terms
Table A1.1 gives an overview of the search blocks and search term categories used 
in the initial search strategy. These included search terms related to refugee and 
migrant health adapted from recent Health Evidence Network synthesis reports and 
the authors’ previous reviews, and associated Medical Subject Headings (MeSH) and 
textwords (tw). Search terms related to the category “availability and integration 
of health data” were omitted to improve the sensitivity of the search strategy.
An initial search of MEDLINE was performed using MeSH/tw combinations 
(Table A1.2). Search terms within a search block were combined using the Boolean 
operator “OR” and then merged with the other blocks using the Boolean operator 
“AND”. Searches were limited by publication date (since 2000), species (human) 
and language (German, English and Russian). This search strategy was adapted for 
other databases and websites, using appropriate combinations of search terms.
English search terms were translated into Russian by two Russian-speaking 
colleagues (Table A1.3) and adapted to the selected Russian databases. The search 
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strategy used for Russian databases was tailored to meet the technical constraints 
of the database or the availability of downloadable citations, and included multiple 
search terms for the population and intervention.
Table A1.1. Search blocks and search term categories
Search block Search term categories
Refugee and migrants Refugees (MeSH)
Human migration (MeSH)
Asylum seeker(s)
Migrant(s)a
Sources of routinely 
collected data
Population surveillance (MeSH; including public 
health surveillance and sentinel surveillance)
Health information systems (MeSH)
Epidemiological monitoring (MeSH)
Routine data
Facility integrated
National, local or nationwide surveillance 
or monitoring systema
Member States of the 
WHO European Region
Europe (MeSH; owing to the wide geographical spread, 
MeSH terms/tw, title/abstract combinations were 
included for each of the 53 WHO Member States)
a Further variations were included while testing the initial search strategy.
Table A1.2. English search terms and combinations for the search in MEDLINE
ID Query Number of hits
19 ID 5 AND 10 AND 15
Filters: publication date from 1 January 2000; 
humans; English; German; Russian
3 430
18 ID 5 AND 10 AND 15
Filters: publication date from 1 January 2000; 
humans; English; Russian
3 331
17 ID 5 AND 10 AND 15
Filters: publication date from 1 January 2000; humans
3 773
16 ID 5 AND 10 AND 15
Filter: humans
4 684
15 ID 5 AND 10 AND 14 5 805
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ID Query Number of hits
14 ID 11 OR 12 OR 13 1 840 228
13 europe[tw] OR EU[tw] OR “european union”[tw] OR “european 
economic area”[tw] OR EEA[tw] OR “WHO European Region” 
[tw] OR “european region”[tw] OR “eastern Europe”[tw] OR 
“Baltic States”[tw] OR “CIS”[tw] OR “Czechoslovakia”[tw]
332 900
12 “Albania”[tw] OR “Andorra”[tw] OR “Armenia”[tw] OR 
“Austria”[tw] OR “Azerbaijan”[tw] OR “Republic of Belarus”[tw] 
OR “Belgium”[tw] OR “Bosnia and Herzegovina”[tw] OR 
“Bulgaria”[tw] OR “Croatia”[tw] OR “Czech Republic”[tw] 
OR “Denmark”[tw] OR “Finland”[tw] OR “France”[tw] OR 
“Georgia (Republic)” [tw] OR “Germany”[tw] OR “Greece”[tw] 
OR “Hungary”[tw] OR “Iceland”[tw] OR “Ireland”[tw] OR 
“Italy”[tw] OR “Luxembourg”[tw] OR “Macedonia”[tw] OR 
“Monaco”[tw] OR “Montenegro”[tw] OR “Netherlands”[tw] 
OR “Norway”[tw] OR “Poland”[tw] OR “Portugal”[tw] 
OR “Moldova”[tw] OR “Romania”[tw] OR “the Russian 
Federation”[tw] OR “San Marino”[tw] OR “Serbia”[tw] 
OR “Slovakia”[tw] OR “Slovenia”[tw] OR “Spain”[tw] OR 
“Sweden”[tw] OR “Switzerland”[tw] OR “Ukraine”[tw] OR 
“United Kingdom”[tw] OR Cyprus[tw] OR Estonia[tw] 
OR Israel[tw] OR Kazakhstan[tw] OR Kyrgyzstan[tw] OR 
Latvia[tw] OR Lithuania[tw] OR Malta[tw] OR Tajikistan[tw] 
OR Turkey[tw] OR Turkmenistan[tw]
1 402 805
11 “Albania”[MeSH] OR “Andorra”[MeSH] OR “Armenia”[MeSH] 
OR “Austria”[MeSH] OR “Azerbaijan”[MeSH] OR 
“Republic of Belarus”[MeSH] OR “Belgium”[MeSH] OR 
“Bosnia and Herzegovina”[MeSH] OR “Bulgaria”[MeSH] 
OR “Croatia”[MeSH] OR “Czech Republic”[MeSH] OR 
“Denmark”[MeSH] OR “Finland”[MeSH] OR “France”[MeSH] 
OR “Georgia (Republic) “[MeSH] OR “Germany”[MeSH] 
OR “Greece”[MeSH] OR “Hungary”[MeSH] OR 
“Iceland”[MeSH] OR “Ireland”[MeSH] OR “Italy”[MeSH] 
OR “Luxembourg”[MeSH] OR “Monaco”[MeSH] OR 
“Montenegro”[MeSH] OR “Netherlands”[MeSH] OR 
“Norway”[MeSH] OR “Poland”[MeSH] OR “Portugal”[MeSH] 
OR “Moldova”[MeSH] OR “Romania”[MeSH] OR “the 
Russian Federation”[MeSH] OR “San Marino”[MeSH] OR 
“Serbia”[MeSH] OR “Slovakia”[MeSH] OR “Slovenia”[MeSH] OR 
“Spain”[MeSH] OR “Sweden”[MeSH] OR “Switzerland”[MeSH] 
OR “Macedonia (Republic)“[MeSH] OR “Ukraine”[MeSH] 
OR “United Kingdom”[MeSH]
1 234 217
10 ID 6 OR 7 OR 8 OR 9 1 319 347
Table A1.2 contd
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ID Query Number of hits
9 surveillance[tw] OR “surveillance system”[tw] OR “surveillance-
system”[tw] OR monitoring[tw] OR “monitoring system”[tw] 
OR “monitoring-system”[tw] OR “sentinel surveillance”[tw] 
OR “syndromic surveillance” OR ((hospital[tw] OR clinic[tw]) 
and (monitoring[tw] OR surveillance[tw])) OR ((hospital[tw] 
OR clinic[tw]) and (“monitoring system”[tw] OR “surveillance 
system”[tw] OR “alert system”[tw] OR “records”[tw])) OR 
((national[tw] OR regional*[tw] OR local[tw] OR international[tw] 
OR governmen*[tw] OR privat[tw] OR facility[tw]) AND 
(“monitoring system”[tw] OR “surveillance system”[tw])) OR 
“data collection system”[tw] OR “health information system”[tw] 
OR “HIS”[tw] OR “register data”[tw] OR “medical records”[tw] 
OR ((“Public Health”[tw] OR “Public Health”[MeSH]) AND 
(“monitoring”[tw] OR “surveillance”[tw] OR “data collection”[tw] 
OR “register” OR “data system”[tw])) OR ((“data collection 
system”[tw] OR “monitoring”[tw] OR “surveillance”[tw] OR 
“health information system”[tw] OR “HIS”[tw]) AND (“health 
services”[tw] OR “emergency”[tw] OR “health system”[tw] OR 
“system resources”[tw] OR “infrastructure”[tw] OR “human 
resources”[tw] OR “financing”[tw] OR “development”[tw] OR 
“system performance”[tw]))
1 319 070
8 “Community Integration”[MeSH] 255
7 “Epidemiological Monitoring”[MeSH] 6 216
6 “Population Surveillance”[MeSH] 63 474
5 ID 1 OR 2 OR 3 OR 4 672 868
4 refugee[tw] OR “asylum seeker”[tw] OR “asyl*”[tw] OR 
(displaced[tw] AND (person*[tw] OR people[tw])) OR 
“migra*”[tw] OR “forced migra*”[tw] OR migration[tw] OR 
immigra*[tw] OR “human migration”[tw] OR stateless[tw] 
OR “state-less”[tw] OR “irregular migra*”[tw] OR “regular 
migra*”[tw] OR “undocumented migra*”[tw] OR “internally 
displaced”[tw] OR “detainees”[tw] OR “residence status”[tw] 
OR “foreign-born”[tw] OR “ displaced person”[tw] OR “non-
citizen”[tw] OR “outsider”[tw] OR “newcomer”[tw] OR “newly 
arrived”[tw] OR “new arrival”[tw] OR “recent entrant”[tw] OR 
“non national”[tw] OR “non-national”[tw] OR “transient”[tw] 
OR “minorities”[tw] OR “ethnic”[tw]
665 130
3 “Transients and Migrants”[MeSH] 10 400
2 “Human Migration”[MeSH] 25 368
1 “Refugees”[MeSH] 8 929
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ID search blocks English Russian
1 refugees беженецы
1 refugee беженец
2 human migration миграция
2 human migration переселение
3 transients and migrants временно пребывающие и мигранты
4 asylum seeker ищущий убежище
4 asylum seeker заявителя на получение 
статуса беженца
4 displaced перемещённое лицо
4 person лицо
4 person персона
4 people население
4 people люди
4 people народ
4 migration миграция
4 forced migration принудительная миграция
4 forced migration высылка
4 forced migration изгнание
4 immigration иммиграция
4 immigration иммиграция населения
4 stateless лицо без гражданства
4 stateless лица без гражданства
4 stateless апатри́д
4 irregular migration нелегальная миграция
4 irregular migration незаконная миграция
4 regular migration легальная миграция
4 regular migration законная миграция
4 undocumented migration незадокументированная миграция
4 internally displaced внутренне перемещённые лица
4 detainees задержанные
4 detainees задержанный
4 detainees арестованный
4 detainees арестованные
4 detainees арестанты
4 detainees арестант
4 detainees заключенные
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4 detainees заключенный
4 detainees осужденный
4 detainees осужденные
4 detainees приговоренные
4 detainees приговоренный
4 residence status статус резидента
4 residence status резидент
4 foreign-born родившиеся за границей
4 foreign-born родившиеся за рубежом
4 displaced person перемещённое лицо
4 non-citizen негражданин
4 non-citizen неграждане
4 outsider иностранец
4 newcomer/newly 
arrived/recent entrant
вновь прибывший
4 newcomer/newly 
arrived/recent entrant
недавно прибывший
4 newcomer/newly 
arrived/recent entrant
новоприбывший
4 non-national иностранный гражданин
4 non-national иностранные граждане
4 transient временно пребывающий
4 minorities меньшиства
4 minorities группа меньшинств
4 ethnic этнический
4 ethnic этнос
4 ethnic малые народы
4 ethnic народность
7 epidemiological 
monitoring
эпидемиологический мониторинг
7 epidemiological 
monitoring
эпидемиологический надзор
7 epidemiological 
monitoring
Социально-гигиенический 
мониторинг
7 epidemiological 
monitoring
Санитарно-эпидемиологический 
контроль
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7 epidemiological 
monitoring
Санитарно-эпидемиологический 
надзор
7 epidemiological 
monitoring
эпиднадзор
8 community integration социальная интеграция
8 community integration интеграция в социум
9 surveillance надзор
9 surveillance наблюдение
9 surveillance system система надзора
9 surveillance system система наблюдения
9 monitoring мониторинг
9 monitoring наблюдение
9 monitoring надзор
9 monitoring контроль
9 monitoring system система мониторинга
9 monitoring system система наблюдения
9 monitoring system система надзора
9 monitoring system система контроля
9 sentinel surveillance дозорный надзор
9 syndromic surveillance синдром надзор
9 hospital/clinic больница
9 hospital/clinic клиника
9 hospital/clinic госпиталь
9 alert system Автоматизированная система 
централизованного оповещения
9 alert system Система экстренного оповещения
9 records записи
9 national национальный
9 national федеральный
9 regional региональный
9 local местный
9 international интернациональный
9 international международный
9 government правительство
9 government кабинет министров
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9 government испольнительный орган
9 government испольнительная власть
9 private приватный
9 private личный
9 private частный
9 facility организация
9 facility учреждение
9 facility институт
9 data collection system система коллекции данных
9 health information 
system
Медицинская информационная 
система
9 register data регистр данные
9 medical records Медицинская карта
9 medical records история болезни
9 public health Общественное здоровье
9 health services службы здравохранения
9 emergency Скорая медицинская помощь
9 emergency Скорая помощь
9 emergency Неотложная помощь
9 infrastructure инфраструктура
9 human resources человеческие ресурсы
9 human resources людские ресурсы
9 human resources кадровая служба
9 financing финансирование
9 development развитие
9 improvement усовершенствование
9 improvement совершенствование
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ANNEx 2. DEFINITIONS OF TERMS 
USED IN THE REVIEW
Definition of terms used in this synthesis report were developed based on the PICo 
approach, which has the following components: population (P), phenomenon 
of interest (I), context (Co) (1). In this review, the population is refugees and 
migrants, the phenomenon of interest is the availability and integration of health 
data in health information systems, and the context is the Member States of the 
WHO European Region (2).
Population
Migrant. Based on the International Organization for Migration’s definition (3), 
this report defines migrant as a person who is moving or has moved across 
an international border or within a country away from their habitual place 
of residence, regardless of (i) their legal status, (ii) whether the movement is 
voluntary or involuntary, (iii) the reason(s) for movement, or (iv) the length 
of stay.
Refugee. This report uses the legal definition of refugee according to the 1951 
Convention and protocol relating to the status of refugees as “any person who… 
owing to well-founded fear of being persecuted for reasons of race, religion, 
nationality, membership of a particular social group or political opinion, 
is outside the country of his nationality and is unable or, owing to such fear, 
is unwilling to avail himself of the protection of that country” (4).
The studies included in this review did not strictly adhere to these definitions. 
Therefore, to avoid misinterpretation and maintain scientific rigour, the Results 
section reports the terms actually used in the studies.
Intervention
Availability. This term refers to the ability of national health information systems 
to generate reliable data on refugee and migrant health and to ensure its 
accessibility when and where needed by defining, collecting, processing and 
(eventually) publishing the data.
Health data. This term encompasses the three domains of health information: 
health determinants, health status and health system performance.
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Health information system. According to WHO, a well-functioning health information 
system as one consisting of all the activities and resources that ensure “the 
production, analysis, dissemination and use of reliable and timely information 
on health determinants, health systems performance and health status”, 
both on regular basis and in emergencies (5). In this report, a health information 
system is considered to consist of the following data sources: population- and 
facility-based data from censuses; household and health monitoring surveys; 
civil registration data; public health surveillance data; medical records; records 
on health services; and health system resources (e.g. human resources, health 
infrastructure, financing) (5). The WHO Health Metrics Network distinguishes 
population-based records from health service/health facility-based records 
(administrative records, service records, health and disease records) (6). 
In accordance with this classification, this report grouped the data sources 
into the following data collection categories:
• population-based records (population register, vital registration, census);• health records (medical records, claims data, disease-specific registers);• notification and surveillance systems (laboratory-based registers, clinical 
case registers, public health services records); and
• health monitoring surveys (population panels, household surveys).
Integration. This term refers to how integral refugee and migrant health data are 
to the collections systems for health data of the general population. That is, 
whether a parallel system for routine data collection on refugee and migrant 
health has been set up, or whether this has been integrated into the existing 
data collection system for the general population in order to that ensure 
comparable, consistent definitions and classification are used for health data.
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ANNEx 4. SOURCES OF ROUTINELY 
COLLECTED DATA
Routine data sources by category and geographical scope are shown in Tables 
A4.1–A4.7.
Table A4.1. Disease-specific registers
Geographical scope Sources
International
Europe DPV (Diabetes-Patienten-Verlaufsdokumentation) Registry 
MONSUE (Monitoring Suicidal Behaviour in Europe)
WHO Regional Office for Europe Multicentre Study on Suicidal 
Behaviour
National
Denmark Danish Cancer Registry
Danish Facial Cleft Database
Danish Health Authority's Central Odontology Register (SCOR)
Danish Psychiatric Central Research Register
National Diabetes Register
Greece Emergency Department Injury Surveillance System (EDISS)
Israel Israel National Cancer Registry (INCR)
National Psychiatric Case Register
Italy National Leprosy Register
Netherlands Netherlands Cancer Registry (NCR)
Psychiatric Case Register
Norway Cancer Registry of Norway
Cardiovascular Disease in Norway (CVDNOR) project
Spain Registry of Non‐fatal and Fatal Occupational Injury in Insured 
Workers (Ministry of Labour and Social Issues)
Sweden National Quality Register on Prostate Cancer of Sweden (NPCR)
Swedish Cancer Registry (IACR)
Swedish Family-Cancer Database
Swedish Hernia Register 
Swedish Melanoma Registry (SweMR)
Swedish National Diabetes Register
The Swedish Stroke Register (Riksstroke)
United Kingdom UK Obstetric Surveillance System (UKOSS)
United States of 
America
Childhood Lead Poisoning Prevention Program (Manchester, NH)
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Geographical scope Sources
Subnational
Germany Baden-Württemberg Diabetes Incidence Register  
(DIARY – EURODIAB TIGER network)
Saarland Cancer Registry (IACR)
Italy Observatory on CO poisonings (Verona)
Rare Diseases Registry, Veneto Region
Reggio Emilia Diabetes Register
Regional Chronic Disease Register (Veneto Region)
Regional Mental Health Information System (Bologna)
Regional Mental Health Information System (Lombardy)
Netherlands Psychiatric Case Register Middle Netherlands (PCR-MN)
Russian Federation Saratov Regional Clinical Dermatovenerologic Dispensary,  
STI notifications
Spain Barcelona Birth Defects Registry (Registro de Defectos Congénitos 
de Barcelona: REDCB)
Sweden Göteborg Myocardial Infarction Register
Note: CO: carbon monoxide.
Table A4.2. Health monitoring surveys
Geographical scope Sources
International
Europe Community‐based Testing (COBATEST) Network
European Social Survey (ESS)
European Working Conditions Survey (EWCS)
WHO Regional Office for Europe Health Behaviour in School-aged 
Children (HSBC) cross-national survey
National
Belgium Belgian Health Interview Survey (BHIS) 2001
Denmark Danish National Health Survey
Finland Health 2011 Survey
Migrant Health and Wellbeing Study (Maamu)
France French National Nutrition and Health Survey (ENNS)
National Reference Centre for Resistance of Mycobacteria to 
Antituberculosis Drugs, annual surveys
Germany Generations and Gender Survey (GGS)
German Health Interview and Examination Survey for Adults 
(DEGS)
Table A4.1 contd
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Geographical scope Sources
Germany (contd) German Health Interview and Examination Survey for Children and 
Adolescents (KiGGS)
German Telephone Health Survey (GSTel03)
Israel Health Behaviour in School-aged Children (HBSC) survey
Israeli National Health Interview Survey
Italy Italian Behavioural Surveillance System (PASSI)
National Health Interview Survey (NHIS)
Netherlands National Growth Studies
Public Health Monitor (PHM)
Poland General Hospital Morbidity Study
Russian Federation Russian Longitudinal Monitoring Survey (RLMS)
Spain Spanish National Health Survey
Sweden Annual Level-of-Living Survey (LNU)
Health Monitoring of the Swiss Migrant Population 2010
Swedish Survey of Living Conditions
Swiss Health Survey
United Kingdom Labour Force Survey (LFS)
National Tuberculosis Survey
Subnational
Netherlands Amsterdam Health Monitor Survey
Sweden Stockholm Public Health Survey 2010 (now Health Stockholm)
Table A4.3. Medical records/utilization data
Geographical scope Sources
National
Denmark Danish Childhood Vaccination Programme
Danish National Health Service Register
Danish National Hospital Register
Danish National Prescription Registry
Regional Laboratory Database
Register of Prevention at Statistics Denmark
Finland Finnish Hospital Discharge Register (FHDR)
Register of Induced Abortions
Germany Statutory health insurance records
Israel National Psychiatric Case Register (PCR)
Table A4.2 contd
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Geographical scope Sources
Netherlands Netherlands Chlamydia Screening Implementation
Register of Psychiatric Hospital Admissions
Norway Health Economics Administration Database
Norwegian Cervical Cancer Screening Programme (NCCSP)
Norwegian Immunisation Registry (SYSVAK) 
Sweden National Hospital Discharge Register (SNHDR)
National hospital records
National Patient Register (inpatient and outpatient)
Prescribed Drug Register
Salut Programme Register (Salut-R)
Swedish Hip Arthroplasty Register
Swedish National Cervical Screening Registry (NKCx)
United Kingdom National Health Service Hospital Episode Statistics (NHS HES)
Subnational
Italy Health Services Reimbursement Database (Veneto)
Hospital Discharge Database (Lazio)
Hospital Discharge Database (Lombardy)
Hospital Discharge Database (Turin)
Hospital Discharge Database (Veneto)
Information System of Emergency Rooms
Lazio Region Hospital Information System
Netherlands Health Insurance Register (Agis)
Russian Federation Tuberculosis Dispensary Smolensk
Spain Regional medical database (Valencia Health Agency)
Regional pharmacy database (Valencia Health Agency)
Sweden Maternal Health Care Register (MHCR – Västerbotten)
Regional Hospital Discharge Register (Stockholm County)
Stockholm County Council administrative databases on healthcare 
consumption
Switzerland Methadone Case Register of Canton Zurich (regional opioid 
maintenance treatment case register)
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Table A4.4. Notification systems for infectious diseases
Geographical scope Sources
International
Europe European Centre for Disease Prevention and Control (ECDC)
European Centre for Epidemiological Monitoring of AIDS
European Network for Tropical Medicine and Travel Health 
(TropNetEurop)
European Surveillance System (TESSy)
European Travel Medicine Network (EuroTravNet)
International GeoSentinel Surveillance Network
National
Denmark National HIV/AIDS surveillance
National Surveillance Register
National TB surveillance system
Finland National Infectious Disease Register (NIDR)
France Mandatory HIV notification system at Institut de Veille Sanitaire 
(InVS)
Germany Notification system for infectious diseases
Greece Hellenic Centre for Infectious Diseases Control (HCIDC) 
National surveillance system
Ireland Tuberculosis notifications at the Irish National Disease Surveillance 
Centre 
Israel National HIV Register
National TB Notification (Ministry of Health)
Italy HIV Surveillance System
National infectious diseases surveillance
National STI surveillance system
TB Notification Register
Malta National TB surveillance system
Netherlands National HIV serosurveillance
Netherlands Tuberculosis Register (NTR)
Norway Mandatory HIV surveillance system
National surveillance system for acute and chronic hepatitis B
National Tuberculosis Register
Norwegian Surveillance System for Communicable Diseases (MSIS)
Portugal TB surveillance system
Spain National Epidemiological Surveillance Service
Sweden InfCareHIV Database
National HIV Register
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Geographical scope Sources
Switzerland Malaria notification system (Federal Office of Public Health)
Mandatory HBV notification system
MDR-TB notifications (Federal Office of Public Health)
National TB surveillance system
Public health agency surveillance database
United Kingdom Enhanced Tuberculosis Surveillance system (TB-ETS)
GUMCAD STI Surveillance System
HIV and AIDS Reporting System (HARS)
HTLV notification at the Communicable Disease Surveillance 
Centre (CDSC)
National Register of Malaria Cases
Surveillance of Infectious Disease
TB Reporting System at the Health Protection Agency in England 
and Wales
Subnational
Greece Syndromic notification system (Athens)
Italy Lazio Region HIV Surveillance System
Modena Region HIV Surveillance System
Multicentre Study on Resistance to Antituberculosis Drugs (SMIRA) 
network
Regional Information System for Infectious Diseases (Umbria)
Regional TB notification system (Emilia-Romagna)
Spain AIDS Register, Barcelona
Catalan Region HIV/AIDS Surveillance System
Galician Tuberculosis Prevention and Control Programme
Malaria Register, Barcelona (Public Health Agency of Barcelona)
United Kingdom East of England enhanced surveillance
HIV Reporting System, Health Protection Agency (England and Wales)
London TB Register
Public Health Laboratory Bristol records
Regional notification of HIV (England, Wales) at the Health 
Protection Agency Centre for Infections
West of England enhanced surveillance
Not specified
Italy Syndromic surveillance system for migrant populations
Notes: HBV: hepatitis B virus; HTLV: human T-lymphotropic virus; MDR-TB: multidrug-resistant 
tuberculosis; STI: sexually transmitted infection.
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Table A4.5. Population-based records
Geographical scope Sources
National
Belgium Census of Belgium
Register of Births (population register system)
Czechia Czech Republic Birth and Baptism Records
Denmark Attainment Register
Central Taxpayers' Register (CSR)
Civil Registration System (CPR)
Danish Medical Birth Register
Danish Register of Causes of Death
National Patient Register
Statistics Denmark
Finland Finnish Causes of Death Register
Medical Birth Register
Population Census
Population Register Centre (VRK)
Germany German Death and Burial Index
German Microcensus 2005
Israel Israel National Civil Census
Israel National Database on Causes of Death
Israel Population Registry
Italy National Cause of Death Register
Netherlands Netherlands National Cause of Death Register
Netherlands Population Register
Norway Cause of Death Register
Medical Birth Registry of Norway (MBRN)
National Register (population)
Norwegian Patient Registry
Statistics Norway
Portugal National Cause of Death Register
Portugal Census
Spain Birth Register (National Statistics Institute)
National Cause of Death Register
Population Registry (National Statistics Institute)
Sweden National Patient Register
Swedish Cancer Registry (IACR)
Swedish Cause of Death Register
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Geographical scope Sources
Sweden (contd) Swedish Census
Swedish Fertility Register
Swedish Medical Birth Register
Swedish Multi-generation Register 
Swedish National Income Register
Swedish Population and Housing Census
Swedish Population Census
Swedish Population Register
United Kingdom National Health Service patient demographic system
Subnational
Italy Lazio Region Mortality Register
Municipal cause of death registers
Municipal population registers
Netherlands Municipal Register, Amsterdam
Spain National Cause of Death Register
Municipal Population Register, Madrid
Sweden Swedish Medical Birth Register
Swedish National Population Register
United Kingdom Lothian Region Birth Register
Table A4.6. Subgroup-specific records
Geographical scope Sources
International
Europe European Migrant Ethnic Health Observatory (MEHO) 
National
Denmark Danish Immigration Service Database
Danish Health Visitor's Child Health Database
Netherlands Electronic medical records database of the Community Health 
Services for Asylum Seekers in the Netherlands (MOA)
Asylum seeker centres mortality notification system
Netherlands Paediatric Surveillance Unit (NSCK)
Sweden Swedish Longitudinal Immigrant Database (LISA)
Swedish National Crime Register
Swedish Persons Convicted of Offences Register
Not specified
Italy Protection System for Refugees and Asylum Seekers (SPRAR) 
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Table A4.7. Other records
Geographical scope Sources
National
Denmark Danish HIV Cohort Study
Integrated Database for Labour Market Research (IDA)
Norway Norwegian Mother and Child Cohort Study
Sweden Swedish Labour Force Survey (LFS)
Swedish Longitudinal Integration Database for Health Insurance 
and Labour Market Studies (LOUISE)
Swedish nationwide research database at Lund University
United Kingdom National Study of HIV in Pregnancy and Childhood Surveillance
Subnational
Denmark Danish Red Cross database
Germany Clinical Surveillance of HIV Disease Cohort (ClinSurv)
Italy Italian Network of Longitudinal Metropolitan Studies (IN-LiMeS)
Italy Home Care Database
Switzerland Swiss Hospital Clinic Primary HIV-1 Infection Cohort
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